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ABSTRACT  
Effective linkage to HIV care and treatment for all people diagnosed with HIV is crucial if 
positive treatment outcomes are to be realised. The study used the client records for all those 
newly diagnosed with HIV through the two entry points for HIV testing between January 2016 
and December 2016. The aim of the study was to determine the proportions between the 
linkages to HIV care and treatment as per entry point for the people diagnosed with HIV at a 
Norton Health Centre in Zimbabwe. More importantly, the study sought to make 
recommendations to improve linkage per entry point. This was achieved through determining 
the proportion of individuals diagnosed with HIV that had documented evidence of linkage to 
HIV care and treatment by entry point. The study also evaluated the association between the 
entry point of HIV diagnosis and the linkage to HIV care and treatment.. In total, 239 clients’ 
records were reviewed who were over the age of 16 years. Overall, 144 (60%) had documented 
evidence of being linked to HIV care while about 95 (40%) of the client records had no 
documented evidence of linkage to HIV care. 143(60%) had documented evidence of initiation 
on antiretroviral therapy (ART) while about 96 (40%) had no documented evidence of initiation 
on ART. A statistically significant association between entry point for HIV diagnosis and the 
linkage to HIV care and treatment was demonstrated. A statistically significant higher 
proportion of females was demonstrated to be linked to HIV care and treatment than for males. 
The Prevention of Mother to Child Transmission of HIV (PMTCT) entry point showed higher 
linkages than OPD and wards entry point. Therefore, there is need to make put measures in 
place that encourage all clients that are diagnosed with HIV through the various entry points at 
the health centre to be linked to HIV care and treatment. The study made recommendations 
based on the findings. It is also recommended that male partners be encouraged to accompany 
their female expectant partners when attending PMTCT sessions. Youth were found to be lower 
in terms of linkages and the youth user friendly centre is recommended so as to attract more 
youths to come for testing. 
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                                                               CHAPTER 1 
                                                        STUDY OVERVIEW 
1.1 INTRODUCTION AND ORIENTATION OF THE STUDY 
This study focuses on the linkage to HIV (Human Immunodeficiency Virus) care and treatment 
for clients diagnosed with HIV at a health centre in Norton, Zimbabwe. The study explores the 
proportions of clients with evidence of linkage to care and treatment as per entry point from 
which they are diagnosed with HIV. The concept of linkage to care and treatment of HIV 
positive clients was coined by World Health Organisation (WHO, 2015). More information is 
discussed in the background to the study as well as paragraphs that follows. 
1.2 BACKGROUND OF THE STUDY 
The World Health Organisation has considered HIV as a global public health concern (WHO, 
2015:112). Approximately 36.9 million people were living with Human Immunodeficiency 
Virus (HIV) globally by the end of 2014. The majority of these people live in sub-Saharan 
Africa (WHO, 2015:112). Zimbabwe has the fifth highest HIV infection rates in the sub-
Saharan region with a prevalence rate of 15% (AVERT, 2016). As of the year 2013, the highest 
number of adults living with HIV in Zimbabwe was found in Manicaland Province and the 
least was found on Matabeleland North Province (Ministry of Health and Childcare [MoHCC], 
2014:29). 
 Although Zimbabwe has seen a decline in new HIV infections among adults by approximately 
50% in the last decade, which translated to a reduction in HIV, as well as related deaths by 
60%, there is still some concern and more effort is still needed to keep the epidemic under 
control (MoHCC, 2014:29). Furthermore, this success has been attributed to highly successful 
HIV prevention, treatment and support programmes. One of these programmes is the 
Opportunistic Infections and Antiretroviral Therapy (ART) Programme introduced by the 
Ministry of Health and Child Care in April 2004 which rolled out ART services countrywide 
(MoHCC, 2015: iii). Despite this success story, Zimbabwe still has low HIV testing rates with 
approximately 66% of its population knowing their HIV status according to the Zimbabwe 
Demographic Health Survey of 2010/11 (MoHCC, 2016:9). 
 The success of any ART programme depends on the timely HIV diagnosis, linkage to care, 
treatment initiation, and retention in care (Losina, Bassett, Giddy, Chetty, Regan, Walensky, 
Ross, Scott, Uhler, Katz, Holst & Freedberg, 2010:2). Early treatment is believed to be 
associated with clinical and HIV prevention benefits, improving survival and reducing the 
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incidence of HIV infection at community level (MoHCC, 2013: 20).  The MoHCC has been 
using the 2013 WHO guidelines for determining ART eligibility and initiation which 
recommended that people with a confirmed HIV diagnosis with a CD4 cell count of 
500cells/mm3 or less or an advanced stage of disease classified as WHO Clinical Stage 3 or 4 
should be started on ART (WHO, 2015:92).  
In 2015, the WHO revised the recommendation which then advocated that all adults diagnosed 
with HIV should be initiated on ART regardless of the CD4 cell count level or the clinical stage 
(WHO, 2016:74). This treatment approach has become to be known as the “Treat All” approach 
(WHO, 2017).  Moreover, these new recommendations are in line with the United Nations Joint 
Programme on HIV/AIDS (UNAIDS) ambitious targets called the “90-90-90”, which are 
aimed at ending the HIV epidemic by the year 2030. These targets aim to have 90% of all 
people living with HIV knowing their status and of these, 90% of them should receive sustained 
ART which should translate to 90% of those people on ART having viral suppression by the 
year 2020 (UNAIDS, 2014:1). 
Achievement of the UNAIDS 90-90-90 targets requires all people diagnosed with HIV to be 
effectively linked to care and treatment. However, these linkages are unacceptably low in sub-
Saharan region with an estimated 40% of the people diagnosed with HIV not linked to care and 
initiating on ART late (WHO, 2016:26). By the end of 2014, approximately 1 168 451 adults 
in Zimbabwe were eligible for ART based on a CD4 cell count of <500 cells/mm3 yet only 
732 919 clients are receiving ART in Zimbabwe, which is only 63% of those eligible 
(Takarinda, Harries & Mutasa-Apollo, 2016:4).  
 
The overall goal of having all people diagnosed with HIV on sustained ART is to be able to 
attain viral suppression, which is an HIV viral load below the detectable threshold using viral 
assays (WHO, 2015: xii). People taking ART who manage to achieve viral suppression will 
not transmit HIV to their sexual partner making it a key strategy in preventing the spread of 
HIV and will also allow them to live healthy longer lives (WHO, 2015: 64; CDC, 2016:1). 
There is a model of sequential stages that people living with HIV go through from HIV 
diagnosis to achieving viral suppression which is called the ‘HIV Continuum of Care’ or the 
‘HIV Treatment Cascade’. In addition, the continuum of care also shows the proportions of the 
people living with HIV that are engaged at each stage (AVERT, 2016).  
The first stage involves the HIV diagnosis and then those people are linked to care as the second 
stage. The care stage involves determining those eligible to proceed to the third stage of ART 
initiation while those eligible yet are retained in care. Lastly, sustained ART should then lead 
3 
 
to viral suppression as the last stage (AVERT, 2016; CDC, 2016). Information from the HIV 
Treatment and Care Programme in Zimbabwe revealed that the highest number of loss to 
follow-up along the HIV treatment cascade occurs between diagnosis with HIV and enrolment 
into care and receiving ART (MoHCC, 2012). 
 Loss to follow-up in HIV care and treatment is a complicated issue that can be influenced by 
multiple factors on the individual, healthcare system and societal level (Gerdts, Wagenaar & 
Farquhar, 2014: e37). The type of HIV testing centre or HIV testing entry point has been found 
to be associated with the loss to follow-up with studies conducted in Mozambique. This study 
also suggests that pregnant women diagnosed through prevention of mother to child 
transmission (PMTCT) centres are less likely to be linked to care and treatment compared to 
people diagnosed through voluntary counselling and testing (VCT) centres (Gerdts et al., 2014: 
e38). 
 
Figure 3.1: Diagrammatic presentation of HIV linkage to care and treatment process at a 
Norton health centre (Tungwarara, 2017) 
Figure 1.1 above demonstrates the process involved in linking people diagnosed with HIV at a 
Norton Health Centre as described by the WHO (2016:243-251).. The entry point is where the 
clients are tested and if they test HIV positive are referred to HIV care for pre-ART care. The 
facility has got two entry points for HIV testing, the first entry point provides testing to all 
clients coming through the out-patients department (OPD) and the ones tested in the wards. 
For this research, the entry point will be referred to as the OPD and Wards entry point. The 
second testing entry point known as the Prevention of Mother to Child Transmission of HIV 
(PMTCT) provides testing to clients accessing the facility for antenatal care (ANC), post-natal 
HIV testing Entry 
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• OPD and Wards
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HIV CARE
Pre ART
• CD4 cell count 
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• WHO Clinical 
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care (PNC) and maternity services. In pre-ART care, the clients go through CD4 cell count test 
and the WHO clinical staging so as to determine if they are eligible to be enrolled on ART. 
CD4 cell count test is a laboratory test that is used to measure the amount of CD4 T 
lymphocytes in a sample of the blood. It is also used as an indicator of the immune system and 
predictor of the progression of HIV (Ford, Meintjes, Vitoria, Greene & Chiller, 2017:123). 
Clinical staging is an HIV classification system that is used in low resource settings that do not 
have access to CD4 cell count testing methods. The classifications range from stage 1 to 4 (US 
Department of Health and Human Services and Health Resources and Services Administration 
2014:95). Those clients found to be eligible will be linked to HIV treatment, which is being 
enrolled on ART. 
 This study aimed at determining the proportions in the linkage to HIV care and treatment as 
per entry point for HIV diagnosis for the people diagnosed with HIV at a Norton Health Centre. 
Based on the information above, the following problem statement was developed for this study. 
1.3 STATEMENT OF THE RESEARCH PROBLEM 
A problem statement is a structured formulation of the problem that is to be addressed or that 
needs to be fixed. The statement is meant to express the troubling situation that needs to be 
investigated and that provides a rationale for a new inquiry (Polit & Beck, 2012:82). The 
success of any ART programme depends on the timely HIV diagnosis, linkage to care, 
treatment initiation, and retention in care (Losina et al.,2010:2). HIV testing and treatment 
services are provided through many entry points at the Norton Health Centre and it has been 
an observation of the researcher from the experiences in other health centres in Zimbabwe that 
these HIV diagnosed people do not come for the follow up linkages to care and treatment. The 
study aimed to identify the proportions of client linkage to HIV care and treatment as per entry 
point of HIV testing as well as to identify whether there is any association between the entry 
points through which people are diagnosed with HIV and the linkage to HIV care and treatment 
outcome. The findings would then be used in making recommendations that ensure that almost 
all clients diagnosed with HIV through the various entry points get treatment. 
1.4 RESEARCH AIM/ PURPOSE 
The aim of this study was to determine the proportions between the linkages to HIV care and 
treatment as per entry point for the people diagnosed with HIV at a Norton Health Centre. More 
importantly, the study sought to make recommendations to improve linkage per entry point. 
The following objectives were developed based on the purpose of the study. 
5 
 
1.5 RESEARCH OBJECTIVES 
In order to achieve the aim of the study, the following objectives were developed: 
• To determine the proportion of individuals diagnosed with HIV that have documented 
evidence of linkage to HIV care and treatment at a Norton Health Centre by entry point. 
• To evaluate the association between the entry point of HIV diagnosis and the linkage 
to HIV care and treatment. 
• To make recommendations for improving the linkages to HIV care and treatment as per 
entry point at a Norton Health Centre. 
1.6 RESEARCH HYPOTHESES 
Based on the above objectives and aim of the study, the following hypothesis were developed 
as described by Polit and Beck (2012:84). Research hypotheses is a prediction about the 
relationship between variables and this hypothesis is applicable when conducting quantitative 
research (Polit & Beck, 2012:84). In addition, the hypotheses attempt to predict the answers to 
the proposed research questions in a study and for the purpose of this study, the following 
hypotheses were made. 
H1: There is a significant relationship between the entry point from which people are diagnosed 
with HIV at the facility and the subsequent low linkage to HIV care and treatment. 
H2: There are more HIV positive females linked to HIV care and treatment than HIV positive 
males at the health facility. 
1.7 SIGNIFICANCE OF THE STUDY 
This study identified the losses occurring at every stage of the HIV continuum of care for 
people diagnosed with HIV at a Norton Health Centre. The study also identified the various 
losses in the linkages to care and treatment as per entry point which can be useful in addressing 
any bottlenecks in some of the entry points.  The Ministry of Health and Child Care of 
Zimbabwe launched the Guidelines for Antiretroviral Therapy for the Prevention and 
Treatment of HIV in Zimbabwe in December 2016 (MoHCC, 2017:3). More importantly, the 
guidelines have seen the roll out of the “treat all” approach for all people diagnosed with HIV. 
So, this retrospective study examines the clients diagnosed prior to “treat all” roll out, therefore 
serving as a baseline study which can be used to assess the impact of the new intervention. This 
study purely focuses on the quantitative aspect of the proportions of the clients diagnosed with 
HIV through the various entry points with evidence to linkage to HIV care and treatment. Any 
significant losses noted will form basis for a qualitative study aimed at exploring the causes of 
6 
 
these losses envisaged to be very helpful in crafting any intervention plan to improve retention 
of clients in care and treatment. 
 
1.8 DEFINITION OF KEY CONCEPTS 
Facility: In the context of HIV testing, facility-based HIV testing services which is commonly 
referred to as Provider Initiated Testing and Counselling (PITC) are those services that are 
offered in a health facility which includes places like clinics, hospitals and primary health 
centres (WHO, 2016: 26). 
HIV: The virus that causes Acquired Immune Deficiency Syndrome (AIDS) and this virus 
targets the immune cells in the body known as the CD4 cells which result in a weakened 
immune system (WHO, 2016: xv). 
Linkage to HIV Care and Treatment: The WHO defines linkage as a process of actions and 
activities that supports people testing for HIV and people diagnosed with HIV in engaging with 
prevention, treatment and care services as appropriate for their HIV status. For people with 
HIV, linkage refers to the period beginning with HIV diagnosis and ending with enrolment in 
care or treatment (WHO 2016: xv). 
Entry Point: According to the WHO (2016), an entry point is the opportunities or gateways 
that can be used to identify the people who can benefit from treatment through the provision 
of HIV testing and counselling. 
Zimbabwe: Zimbabwe is a landlocked country that is situated in Southern Africa covering an 
estimated area of 390 784 km2 (Kerina, Pedersen & Muller, 2013:1). Zimbabwe borders 
Mozambique, South Africa, Botswana, and Zambia. The country has a population of 
13 061 239 people with women making up 52% and 48% men as of the 2012 Census (UN 
2014). 
1.8.1 OPERATIONAL DEFINITION OF TERMS 
The definitions given below are the operational definitions that were adopted in this study: 
Facility: In this study, a facility is referred to as a health centre that provides HIV testing and 
treatment services in Norton region. 
HIV: HIV refers to the virus that causes the body to lose its defence mechanism and making 
the body unable to defend itself against any form of infection. 
Treatment: In this study, treatment refers to the medication taken for the treatment of HIV in 
an attempt to strengthen the body. 
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Linkage to HIV Care and Treatment: In this study, linkage to HIV care will refer to the first 
documented attendance for CD4 or WHO clinical staging within 60 days of HIV diagnosis. 
Linkage to HIV treatment will refer to documented initiation on ART within 90 days of HIV 
diagnosis for those who are recorded as ART eligible.  
Entry Point: In this study, the entry points will refer to the gateways through which people 
can receive HIV testing and treatment services at the health centre and these are namely 
outpatients’ department (OPD), voluntary counselling and testing (VCT), antenatal care 
(ANC), tuberculosis clinic (TB) and wards that provide HIV testing services. The following 
paragraphs will discuss the research methodology used in this study. 
1.9 RESEARCH DESIGN AND METHOD 
1.9.1 Research Methodology 
Research methodology is the systematic way in which the researcher intends to solve the 
research problem, collect the data, analyse, and interpret the findings (Creswell, 2009:233). 
Accordingly, the study follows a quantitative approach. Quantitative research is an approach 
that is used to test objective theories through examining the relationship among variables and 
these variables can be measured using various instruments so that the numbered data can be 
analysed using statistical procedures (Creswell, 2014:32). More information on the choice of 
research methodology will be discussed in detail in Chapter Four.  
1.9.2 Research Design 
According to Kumar (2011: 95), a research design is a strategy or plan of investigation that is 
used in order to get answers to research questions or problems. This study followed the 
quantitative approach that utilised a retrospective descriptive research design. Furthermore, 
descriptive research involves the examination of the situation as it is in its current state and this 
can be achieved through the identification of attributes of a particular phenomenon based on 
an observational basis, or the exploration of correlation between two or more phenomena 
(Williams, 2011:66).  
The descriptive study can be conducted as a retrospective study in which the investigator 
studies a phenomenon, situation or a problem that has occurred in the past and formulates ideas 
about possible associations and investigate potential relationships (Kumar, 2011:110). More 
importantly, this design is the most suitable since the study examined a phenomenon of people 
failing to be linked to HIV care and treatment despite having tested HIV positive. To have an 
understanding on how the entry points through which the clients were tested for HIV could 
have an association with the linkage to HIV care and treatment proportions, there is need to 
8 
 
retrospectively visit the records and make evaluations. More information is discussed in detail 
in Chapter Three. 
1.9.3 Research Setting 
 Research setting is defined as the physical location and conditions in which data collection 
takes place in a study (Polit & Beck, 2017:744). This research was conducted at Health Centre 
in a town called Norton in Zimbabwe. Norton is a small town that lies about 40 kilometres west 
of the capital city Harare along the highway linking Harare and Bulawayo. It is found in 
Mashonaland West Province. According to the 2010 National Census, Norton has a population 
of 67 591 people. 
1.9.4 Research Population  
A population is the entire aggregation of cases in which a researcher is interested (Polit & Beck, 
2012:273). It is common practice in descriptive studies to define the study population first and 
then make observations on the sample taken from it (Banerjee & Chaudhury, 2011:8).  The 
study population was made up of clients who tested HIV positive between January 2016 and 
December 2016 through the three entry points at Norton Health Centre. The total population 
for this study was approximately 520 client records. The population was drawn from the 
various entry points for HIV testing at the health centre. 
Inclusion criteria: Inclusion criteria: Clients of 16 years and above testing HIV positive for 
the first time at the Norton Health Centre between January 2016 to December 2016. The 
decision of having the age limit at 16 years was to conform with the Ministry of Health and 
Child Care’s consent age for HIV testing services, which is 16 years or older (MoHCC, 
2017:34).  
Exclusion criteria: Clients under the age of 16 years testing positive for the first time. Clients 
with an already known HIV positive status. Therefore, any client who does not fit in the period 
of the study was excluded. 
 
1.9.4.1 Sampling 
Kumar (2011:176) define sampling as the process of selecting study units from a defined study 
population in order to make an inference about the whole population. In this study, 
proportionate stratified probability sampling was used. According to Polit and Beck 
(2017:740), probability sampling is defined as the selection of sampling elements from a 
population using a random procedure. Proportionate stratified probability sampling as defined 
by Kumar (2011:185) is sampling in which the number of elements in each stratum in relation 
to its proportion in the population is selected using a random procedure. The entry points will 
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form the strata and the respective proportions to the total number of HIV positive clients will 
determine the sample size from each entry point. 
The minimum sample size was calculated using the Raosoft Software (Raosoft, 2016). The 
formula takes into account of the confidence level, margin of error and the population size to 
be used in the study. The confidence level for this study was 95% and the margin of error was 
5% and the population size was approximately 520 client records. The minimum sample size 
calculated for this population was approximately 258 records. Since there are various entry 
points that have varying sizes of population, proportionate stratified probability sampling was 
applied to come up with the 258 records. The formula that was used to determine the sample 
size is as follows: 
x=Z(c/100)2 r (100-r) 
n=N x/ ((N-1)E2 + x)                          E=Sqrt[(N - n)x/n(N-1)] 
1.9.5 Data Collection 
Data collection refers to the process of gathering and measuring information on variables of 
interest, in an established systematic fashion that allows the researcher to test the stated 
hypotheses, and evaluate outcomes (Polit & Beck, 2017:725). The data were collected from a 
Norton Health Centre using the records of the clients who tested HIV positive. The study 
involved retrospectively tracing clients’ records that tested HIV positive between January and 
December 2016 at the Norton Health Centre to determine documented uptake of subsequent 
HIV care and treatment services. The data for this study were obtained from the HIV 
management registers, namely, the HIV Testing and Counselling (HTC) register, Pre-ART 
register and the ART register from the outpatients’ department (OPD), antenatal care (ANC) 
clinic, Tuberculosis (TB) clinic, voluntary testing and counselling (VCT) entry points and the 
wards that provide HTS. The electronic patient management system (ePMS) and OI/ART 
patient care booklets were used to trace some of the individual care and treatment outcomes. 
1.9.6 Data Analysis 
Data analysis involves the systematic organisation and synthesis of research data and in 
quantitative data, the testing of hypothesis using the data (Polit & Beck, 2017: 725). The 
collected data were entered on the data capturing platform. The data were analysed using Epi 
Info version 7 Statistical Software (Centre for Disease Control and Prevention, Atlanta, GA). 
Proportions of clients linked to HIV care and treatment were calculated for the three entry 
points involved in the research. In addition, the data was interpreted using the mean (M), 
standard deviation (SD) and correlations. Data were kept safe behind lock and key with the 
researcher and only the people involved in research having access. 
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1.10 RELIABILITY AND VALIDITY 
Reliability is a characteristic of an instrument that reflects the extent to which the instrument 
provokes consistent responses. Reliability of a research instrument in quantitative research is 
the extent to which the same results can consistently be obtained upon using the instrument in 
the same situation on repeated occasions (Heale & Twycross, 2015:66). Reliability of the 
checklist used in this study were evaluated for equivalence. This is the degree of consistency 
in providing measurements of the same attributes and is of concern when different observers 
are using the same instrument to collect data at the same time (Brockopp & Hastings-Tolsma, 
2003:217). 
 Validity is the ability of an instrument to measure what is designed to measure (Kumar, 
2011:166). The instrument used in this study included a checklist and the measures taken to 
ensure content validity and construct validity. Content validity looks at whether the instrument 
adequately covers almost all the content it should cover with respect to the variables under 
study which is linkage to HIV care and treatment (Heale & Twycross, 2015:66). Therefore, the 
researcher ensured content validity by developing a checklist that took into account of all the 
processes and stages that constituted linkage to HIV care and treatment. The checklist was 
crafted in a way that every stage of the HIV continuum of care was answered. Construct validity 
refers to the extent to which inferences can be drawn about test scores in relation to the concept 
being studied, in this case linkages to HIV care and treatment (Heale &Twycross, 2015:66). It 
is the extent to which the checklist to be used is measuring the linkages to care and treatment 
and this was ensured through homogeneity in all the elements of the checklist. 
 
1.11 ETHICAL CONSIDERATIONS 
Research ethics govern the standards of conduct of scientific research with the aim of 
protecting the dignity, rights and welfare of the research participants. An ethics committee to 
ensure that appropriate ethical standards are being upheld should review the research involving 
human participants (WHO, 2017). The researcher sought ethical clearance from University of 
South Africa Higher Degrees Research and Ethics Committee (Annexure A) and also from the 
Medical Research Council of Zimbabwe (MRCZ) (Annexure C) to conduct the research. In 
addition, permission was also sought at the Norton Health Centre to conduct the research 
(Annexure D).  
To protect the privacy of the clients that had their records used in the study, no individual client 
identifiers were included in the data analysis and reporting of findings at all. The researcher 
saw it appropriate not to seek individual consent from the clients because of the reason 
11 
 
mentioned above. The data collection instruments used in this study was always kept in a secure 
place and the only people that who had access to them are those that were directly involved in 
the study. In addition, the selection of the client records that were used for the study was 
conducted through random processes so as to not prejudice any client’s records from being 
included in the study. The researcher did not hold back any information from the Norton Health 
Centre Management and also shared the findings of the study with them. 
1.12 CONCLUSION 
The chapter provided a background about the burden of HIV/AIDS in the world as whole, 
specifically in the sub-Saharan African region. There was also discussion on the 
recommendations that have been put in place by the WHO for the management of HIV. The 
chapter discussed the research problem, aim of the investigation, specific objectives, the 
research hypotheses, the research design that is going to be employed and also the sampling 
methods that will be used to select the participants. There was also discussion of the data 
collection methods, analysis plans and ethical considerations to be taken in conducting the 
investigations. The next chapter focuses on the detailed literature review for the study. 
 
1.13 Chapter layout  
The dissertation will be arranged into five chapters: 
Chapter 1: Study overview. 
Chapter 2: Literature review. 
Chapter 3: Research design and methodology. 
Chapter 4: Analysis, presentation and description of research findings. 
Chapter 5: Conclusion and recommendations. 
 
                                                             
 
 
 
                                                            CHAPTER TWO 
                                                      LITERATURE REVIEW 
2.1 INTRODUCTION 
The previous chapter provided the overview of the study. This chapter focuses on the literature 
review related to the research area. Literature review is a critical summary of research done on 
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a certain topic of interest with the aim of putting a research problem into context (Polit & Beck, 
2012:732). This chapter presents the review of relevant published works related to the linkages 
of HIV positive people to care and treatment at facility level that guides this study. The 
literature presented in this chapter was reviewed from journals, textbooks, online articles and 
operational guidelines and manuals guiding the management of HIV. In reviewing the 
literature, the following scientific search engines were used google scholar 
(www.scholar.google.com), PubMed-NCBI (www.ncbi.nlm.nih.gov/pubmed). The reviewed 
literature is discussed in the paragraphs that follow. 
2.2 HIV EPIDEMIC 
It is now about 36 years since acquired immunodeficiency syndrome (AIDS) and Human 
Immunodeficiency Virus (HIV) were first diagnosed and discovered in 1981. There has been 
considerable progress made in combating the epidemic. In addition, HIV remains a major 
global public health problem despite the significant decline in the number of new HIV 
infections and AIDS-related deaths that have been reported worldwide (Granich, Gupta, Hersh, 
Brian Williams, Montaner, Young & Zuniga, 2015:2). HIV attacks the body’s immune system 
and if left undiagnosed and/or untreated, HIV can gradually weaken the immune system, 
making it more difficult for the infected person to fight off diseases, ultimately a condition 
known as AIDS (CDC, 2017). To date, more than 78 million people have been infected with 
HIV globally, and more than 39 million have died of AIDS. Worldwide, more than 40% of 
new infections among adults are in young people 15 to 24 years of age (Boston University, 
2016). According to the World Health Organisation (WHO) (2017), there were approximately 
36.7 million people living with HIV globally by the end of 2015 with the majority of these 
people living in sub-Saharan Africa. It is also said that one in every 25 (4.4%) adults lives with 
HIV and accounts for nearly 70% of the people living with HIV worldwide (WHO, 2017; 
Takarinda, Harries & Mutasa-Apollo, 2016:3).  
According to the WHO /UNAIDS estimates, HIV prevention programmes have reduced the 
annual number of people being infected with HIV to 2.1 million [1.8 million-2.4 million] in 
2015, which marks a 35% reduction in the incidence since the year 2000 (WHO, 2016:7). 
Moreover, there is strong belief that this decline in incidence was driven by changes in risky 
behaviour (WHO, 2016:11). The expansion in the coverage of antiretroviral therapy (ART) has 
helped reduce the number of HIV-related deaths worldwide to about 1.1 million [940 000 – 1.3 
million] in 2015, which is 45% fewer than in 2005 when HIV-related mortality peaked to 2.2 
million [2.1 -2.4 million] (WHO, 2011: 4; WHO, 2016:6).  
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Sub-Saharan Africa has suffered the most from the burden of the HIV/AIDS pandemic. As of 
the end of 2015, there were a total of 19 million people living with HIV in East and Southern 
Africa. Of these 19 million people, women account for more than 50% (UNAIDS, 2017:2). 
More importantly, the sub-Saharan African region had seen a decline of approximately 14% in 
the incidence of HIV infections between the year 2010 and 2015 to a figure about 960 000 new 
HIV infections in 2015. Subsequently, this drop in HIV incidence translated to a reduction in 
the number of AIDS-related deaths in the year 2015 to 470 000 people, which is a 38% drop 
from the deaths in 2010 (UNAIDS, 2016:2). Furthermore, this reduction of AIDS-related 
deaths and also steady decline in the new HIV infections has been attributed to the scale up of 
antiretroviral therapy (ART) in the last 17 years making it one of the world’s greatest public 
health success stories (Takarinda et al, 2016:3). 
 
2.3 HIV EPIDEMIC IN ZIMBABWE 
The first case of HIV in Zimbabwe was reported in 1985, with an estimated 1,4 million people 
living with HIV in 2013 (Ministry of Health and Child Care [MoHCC], 2014:6, 2015:24). 
Zimbabwe has the fifth highest HIV infection rates in the sub-Saharan region with a prevalence 
rate among women and men aged 15-49 of 13.8% (Zimbabwe Demographic Health Survey 
[ZDHS] 2015:275). The HIV prevalence in the country rose from 1985 and reached a peak of 
27.7% in 1997 and then started declining thereafter (MoHCC, 2014:6). The country has a 
generalised, feminised and homogeneous HIV epidemic with a significantly high level of 
prevalence in the past as compared to the current levels (MoHCC), 2015:12). According to the 
ZDHS in 2015, the highest number of adults living with HIV in Zimbabwe was found in 
Matebeleland South Province and the least was found on Manicaland Province. HIV prevalence 
is higher among women with primary education than among those with no education or with 
higher educational attainment while there is very little variation in men (ZDHS, 2015:276). 
Zimbabwe has seen a decline in new HIV infections among adults by approximately 50% in 
the last decade, which translated into a reduction in HIV-related deaths by 60% (MoHCC, 
2015:12). Zimbabwe’s epidemic contracted more steeply and dramatically more than any other 
epidemic in the East and Southern African region. This decline has been attributed to the impact 
of the various HIV prevention programmes aimed at behaviour change like but not limited to 
high condom use and reduction in multiple sexual partners, elimination of Mother to Child 
Transmission (eMTCT) and successful treatment care and support services (MoHCC, 2014:6). 
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2.3.1 Modes of Transmission 
Transmission is defined as the passing of a pathogen causing a communicable disease from an 
infected individual or group to another individual or group. HIV transmission. Heterosexual 
intercourse has remained the main mode of HIV transmission in sub-Saharan Africa although 
there has been recent epidemiological evidence that indicates some diverse modes of 
transmission. These include sharing of needles among drug users and unprotected sex among 
men who have sex with other men (UNAIDS, 2008:1). Zimbabwe has a generalised 
heterosexually driven HIV epidemic, which accounts for 92% of the transmissions and vertical 
transmission accounting for 7% of the transmissions (MoHCC, 2015:23). 
2.3.2 Zimbabwe’s Response to the HIV Pandemic 
The government of Zimbabwe joined the rest of the world in the fight against HIV that is 
evidenced by the development of a policy environment for the prevention of HIV culminating 
in a multi-sectoral approach led by a national coordination authority and guided by evidence-
informed strategic frameworks (National AIDS Council [NAC], 2011:13). The National Policy 
on HIV and AIDS was adopted in the year 1999 and this led to the creation of the National 
AIDS Council through an Act of Parliament (NAC, 2011: xii). In the year 2000, the 
government of Zimbabwe introduced 3% AIDS levy on all taxable income with the funds 
dedicated towards AIDS programmes and this has led to a 40% increase in the domestic 
financing for HIV between 2011 and 2014 (UNAIDS 2017).  
The Ministry of Health and Child Care introduced the Opportunistic Infections and 
Antiretroviral Therapy (ART) Programme in April 2004, which rolled out ART services 
countrywide (MoHCC, 2015: iii). Zimbabwe National HIV and AIDS Strategic Plan 2011-
2015 has seen the country adopting a combination of approaches that are meant at reducing 
transmission of HIV. These approaches include but not limited to prevention of mother-to-
child transmission (PMTCT), voluntary medical male circumcision (VMMC), behaviour 
change communication, condom programming and sexually transmitted infections (STI) 
management (Avert, 2017). 
Accordingly, the Zimbabwean government has joined the rest of the world in trying to 
eliminate the HIV pandemic by the year 2030. This has been through the implementation of 
the WHO (2013) consolidated guidelines on the use of antiretroviral drugs for the treatment 
and prevention of HIV infection. In 2013, the WHO guidelines recommended that ART should 
be given to all people diagnosed with HIV with a CD4 cell count of less than or equal to 500 
cells/mm3 or a WHO clinical staging of 3 and 4 in places where CD4 cell tests are not available 
(MoHCC, 2013:13). In 2015, WHO issued revised guidelines which recommend the provision 
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ART to all adults living with HIV regardless of the WHO clinical stage and at any level of CD4 
cell count (WHO, 2016:74). As a result, Zimbabwe has since adopted these guidelines with the 
programme rolled out in 6 learning districts in July 2016 followed by a nationwide roll out in 
January 2017 (Engelsmann, Chitiyo, Maphosa, Page-Mtongwiza, Patel, Nesara & Webb, 
2017:1). This treatment approach has become to be known as the “Treat All” or “Test and 
Treat” approach and it aims at increasing the uptake of ART and linkage to care and also 
reduces the time between HIV diagnosis and ART initiation regardless of the baseline CD4 
value (Takarinda et al., 2016:3; Fox & Rosen, 2017:2).  
With the adoption of this Treat All approach, Zimbabwe has joined the rest of the world in 
trying to eliminate the HIV epidemic by the year 2030. This ambitious target is being 
implemented through the 2014 UNAIDS 90-90-90 treatment targets, which aim to have: 
• Ninety percent (90%) of all people living with HIV knowing their HIV status by 2020. 
• Ninety percent (90%) of those people diagnosed with HIV should be receiving 
sustained antiretroviral therapy by 2020. 
• Ninety percent (90%) of those people receiving antiretroviral therapy should have viral 
suppression by 2020 (UNAIDS, 2014:1). 
 
Figure 2.4:90-90-90 HIV Treatment Targets                                                 adopted from www.avert.org/global-hiv-targets 
The figure 2.1 above shows an infographic adopted from the Avert website showing the 90-
90-90 treatment targets. 
Reaching Target 1: 90 % of all people living with HIV will know their status by 2020- 
According to UNAIDS (2014:16), many African countries are within reach of having 90% of 
their population having been tested for HIV at least once. However, only 45% of the people 
living in sub-Saharan Africa know their status, making it imperative to scale up focused and 
frequent testing and also strategic targeting of HIV testing services.  According to the 
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According to the Zimbabwe Population based HIV Impact Assessment ([ZIMPHIA] 2016: 3), 
there were 74.2% of PLHIV in Zimbabwe who knew their HIV status. 
Reaching Target 2: 90 % of all people living with HIV will receive sustained antiretroviral 
therapy - The Fast-Track targets call for reducing the number of people dying from HIV-
related causes to less than 500 000 globally in 2020 and this can be achieved by making sure 
that almost all the people diagnosed with HIV are on antiretroviral treatment (WHO 2016:26). 
Zimbabwe is on course to achieve the 90% target as evidenced by the 62% ART coverage in 
the year 2015 with 9000 new ART initiations every month (MoHCC, 2016:14). 
 
Reaching Target 3: 90% of all people receiving ART will have viral suppression- 
Countries and some programmes have managed to achieve the 90% viral load suppression 
demonstrating the feasibility of this ambition with Rwanda managing to have 83% of people 
on ART having viral suppression between 2008-2009 (UNAIDS, 2014:20). The ZIMPHIA 
(2016:3) findings show that Zimbabwe is almost about to achieve the target evidenced by 
86.5% of PLHIV aged between 15-64 years having viral suppression. 
There are however challenges that Zimbabwe as a country is experiencing in the process of 
trying to achieve the 90-90-90 targets. The country still has a large number of undiagnosed 
people living with HIV who could be identified in the early stages of infection (Takarinda et 
al.,2016:3). There are also other health systems related factors in Zimbabwe that make access 
to HIV care and treatment difficult. A qualitative study on the challenges for ‘test and treat’ in 
eastern and southern Africa found that the closeness or distance to HIV services has an effect 
in shaping the people’s motivation and readiness for testing and starting treatment (Skovdal, 
M.,Nyamukapa, C., Wamoyi, J., Ddaaki, W., Bukenya, D., Renju,J., McLean, E., Moshabela, 
M., Seeley, J.,Bonnington,O. & Wringe A (2015:1).The need to increase the cohort size of 
people on lifelong ART in Zimbabwe will increase the financial burden on the already 
struggling health financing system (Mudadigwa, 2015) .  
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2.4 HIV TREATMENT 
For people living with HIV to fully benefit from potent combination of ART, there is need for 
them to get to know that they are infected, be engaged in regular HIV care and receive and 
adhere to ART (Gardner, Mclees, Steiner, del Rio & Burman 2011:793). The management of 
people living with HIV is best described using the HIV Treatment Cascade or the HIV 
Continuum of Care shown in Figure 2.2 below, as these are names that are commonly used 
interchangeably. First depicted in the United States of America (USA), the HIV treatment 
cascade is an internationally recognised framework that is used to represent that HIV care as it 
progresses from the diagnosis, to enrolment in care, initiation on ART treatment and ultimately 
viral suppression (Kay, Batey & Mugavero, 2016:1). The treatment cascade used in this 
discussion in figure 2.2 is based on the 2013 WHO ART guidelines and will also be compared 
to the changes that the “treat all” has brought to the cascade. Similarly, the treatment cascade 
that is based on the 2013 WHO ART guidelines describes the progression of people living with 
HIV (PLHIV) through HIV testing and counselling, access to and linkage to care. Furthermore, 
eligibility assessment and clinical staging for ART, pre-ART care, ART initiation and lifelong 
ART adherence and retention in care (Layer, Kennedy, Beckham, Mbwambo, Likindikodi, 
Davis, Kerrigan & Brahmbhatt, 2014:8). 
The following paragraphs discuss the HIV treatment cascade as per WHO 2013.  
2.4.1 STEP 1: TESTING TO ENROLMENT 
According to the MoHCC (2017:31), accessible and acceptable access to HIV testing services 
is the first critical step of the HIV treatment cascade. Zimbabwe Demographic and Health 
Survey (ZDHS) of 2010–2011 showed that only 57% of women and 36% of men aged 15–49 
years had ever been tested for HIV (Takarinda et al., 2016:3). 
 
Step 1
Testing to 
enrolment
Step 2
Enrolment to 
eligibility
Step 3
Eligibility to 
initiation
Step 4
initiation to 
lifelong ART
Figure 2.2: HIV Treatment Cascade as per WHO (2013:56) 
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2.4.1.1 HIV Diagnosis 
According to WHO (2015:2), HIV testing is the gateway to HIV prevention, care and other 
support services that may follow. Accordingly, this makes HIV diagnosis the entry route into 
the treatment cascade. Globally, HIV testing remains the biggest challenge to achieving the 
first 90 of the UNAIDS 90-90-90 targets as evidenced by 40% of the 36.7 million people 
around the world living with HIV unaware of their status at the end of 2015 (WHO, 2016:23; 
MoHCC, 2017:31). HIV testing services (HTS) is a phrase used to refer to the full range of 
services that are supposed to be provided with HIV testing which include both pre-test and 
post-test counselling, linkage to the appropriate HIV prevention, treatment and care and other 
clinical services (WHO, 2015:66). The role of HIV testing is to identify all people with HIV 
so that they and their families can be effectively linked to HIV treatment, care and support and 
also HIV prevention services depending on their status (WHO, 2015:66).  
According to Ministry of Health and Child Care document (2017: 22), about 1581(96%) of all 
the facilities in Zimbabwe provide HTS and this has led to 2.2 million people having been 
tested in 2015. Most African countries are within reach of having 90% of people living with 
HIV having been tested at least once. However, sub-Saharan Africa has only 45% of PLWHIV 
who know their status (UNAIDS, 2014:16). According to the Zimbabwe Population based HIV 
Impact Assessment ([ZIMPHIA] 2016: 3), Zimbabwe is on course to achieve the “first 90%” 
as witnessed by the 74.2% of PLHIV between the ages of 15-64 years reporting to being aware 
of their HIV status. 
2.4.1.2 HIV Testing Models 
HIV Counselling and Testing (HCT) serves as an entry point for HIV prevention services that 
include prevention of mother-to-child transmission (PMTCT), male medical circumcision, 
access to condoms, and offer counselling for HIV-positives (Mabuto, Latka, Kuwane, 
Churchyard, Charalambous, & Hoffmann, 2014:1). The WHO recommends that HTS should 
be made available through a wide range of approaches both in the health facilities, free-standing 
sites and a wide range of community-based approaches as suitable for the local epidemiology 
and context and these are known as the “HIV testing models” (WHO, 2015: 38).  
2.4.1.3 Facility-based HIV testing services 
The WHO (2015) highly recommends the integration of HTS with other clinical services so as 
to make HTS more accessible to people visiting health facilities for other reasons and also 
increase the uptake of HTS. Furthermore, WHO (2016:26) postulates that facility-based HIV 
testing services refers to the HTS provided in a health facility or laboratory setting. Examples 
of these testing services include voluntary counselling and testing (VCT), provider-initiated 
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testing and counselling (PITC), testing for TB through HIV services and testing for both HIV 
and other sexually transmitted infections (STIs) (WHO, 2015:48). The Zimbabwean 
government through the “HIV differentiated care model” recommends that facility-based HTS 
should be provided within antenatal care (ANC), at tuberculosis (TB) clinics, at STI and 
outpatient clinics, in medical, surgical and paediatric wards. In addition, HTS should also be 
offered in maternal, newborn and child health (MNCH) services, family planning, adolescent 
sexual reproductive health (SRH), nutrition, mental health and voluntary medical male 
circumcision services (MoHCC, 2017:31). This recommendation was made as a way of trying 
to adapt HIV services across the cascade to reflect the preferences and expectations of various 
groups of people living with HIV (PLHIV) while reducing unnecessary burdens on the health 
system (MoHCC, 2017:29). However, HIV testing is not an efficient and patient friendly 
process as the rapid test results can take nearly half an hour to be ready. Therefore, this makes 
integration to other health services a better option as it will reduce the overall time spent by the 
client at the facility and also reduce the burden health systems have to go through should the 
services be offered independently (Kay et al., 2016:2). A study conducted in South Africa on 
the utilisation of the various HIV testing models found that the proportion of men that tested 
was slightly higher in the community units compared to the facility based testing (Mabuto et 
al.,2014: 6). 
 
2.4.1.4 Community based HIV testing services 
Community-based HIV testing and counselling is defined as HTC that is conducted outside of 
a health facility (Sharma, Ying, Tarr & Barnabas, 2015: 2). These modalities include testing 
conducted at community sites that include places like religious institutions, schools, 
workplaces, and at home. It also includes mobile testing conducted through mobile vans or 
tents mainly targeting places of entertainment like bars and clubs (WHO, 2015:27). This testing 
model mainly targets first-time testers and those people who do not normally use clinical 
services, and also people from key populations. Existing evaluations indicate that community-
based testing greatly increases uptake of HTC and helps identify new HIV cases at earlier 
stages of the disease as. To add on, the costs of community-based testing are also relatively 
lower than the facility-based testing (Helleringer, S., Mkandawire, J., Reniers, G., Kalilani-
Phiri, L., & Kohler, H. 2012:1). 
2.4.2 STEP 2: ENROLMENT TO ELIGIBILITY 
The main goal of enrolling people living with HIV in care is to provide the people with  
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 an opportunity for close clinical and laboratory monitoring and early assessment of 
eligibility for ART and timely initiation and aims to minimise loss to follow-up. 
2.4.2.1 Linkage to HIV care and retention 
Linkage to care is the second step in the HIV treatment cascade and it has been described as 
the ‘Achilles heel’ of the treatment cascade (Labhardt, Ringera, Lejone, Masethothi, 
Thaanyane, Kamele, Gupta, Thin, Cerutti, Klimkait, Fritz & Glass, 2016:2). It is very important 
for all people living with HIV to enrol into care as soon as possible so as to facilitate early 
assessment for ART eligibility and timely ART initiation (WHO, 2013:86). There are varying 
definitions to linkage to care. The CDC and the Institute of Medicine (IOM) refer “linkage to 
care” as the period of three months or less between the documentation of diagnosis and the 
beginning of medical treatment with an HIV care provider (Kay et al., 2016:3). On the contrary, 
WHO defines linkage as a process of actions and activities that support people testing for HIV 
and people diagnosed with HIV in engaging with prevention, treatment and care services as 
appropriate for their HIV status. In addition, for people with HIV, linkage refers to the period 
beginning with HIV diagnosis and ending with enrolment in care or treatment (WHO, 2016: 
xv).  
 Low or delays in linking the population to care can lead to those diagnosed with HIV failing 
to benefit from HIV care which will have a resultant effect of increased transmission of HIV 
(Sanga, Lerebo, Mushi, Clowes, Olomi, Maboko & Zarowsky, 2016: 2). From a study 
conducted in 18 states in the USA by CDC, it was revealed that 28% of HIV infected people 
had delayed entry into care (Mayer, 2011: S205). Another study conducted in the USA in 2009 
revealed that 90% of the cases of HIV transmission were attributable to HIV individuals who 
were either undiagnosed or were diagnosed but not linked to care, with those not linked to care 
accounting for twice as many cases as the undiagnosed (Mugavero, 2016:116). It is estimated 
that about 57% of people who are diagnosed with HIV in sub-Saharan Africa are linked to care 
(WHO, 2015:243). This means that approximately 43% remainder of the people living with 
HIV are not accessing any treatment exposing them to the risk of spreading the infection and 
also increasing the risk of dying from HIV-related diseases. 
A cohort study conducted in Tanzania that prospectively followed newly HIV diagnosed clients 
over a period of 3.5 years found that 30% of those who tested HIV positive did not have timely 
linkage to care and also linkage to HIV treatment was frequently delayed (Reddy, Agala, Maro, 
Ostermann, Pence, Itemba, Safley, Yao, Thielman &Whetten, 2016:5). These delays will have 
a negative effect on the treatment prognosis. According to the WHO (2016:243), patient 
attrition after HIV diagnosis has become a huge global public health problem contributing to 
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delayed ART initiation, avoidable morbidity, mortality and increased cost of care and 
preventable HIV transmission. This is the reason why linkage to care immediately after HIV 
diagnosis is important to prevent these losses. 
 
2.4.2.2 Services offered in the Care Package 
The WHO recommends countries to have established general HIV care interventions to 
compliment ART for all people living with HIV so as to reduce HIV transmission, prevent 
illness and also improve their quality of life (WHO, 2013:86).  This organisation also 
recommended a package of 13 interventions meant for adults and adolescents living with HIV 
in low resource settings. The package includes interventions such as but not limited to 
psychosocial counselling and support, disclosure and partner notification, co-trimoxazole 
preventative therapy, TB counselling, screening and preventative therapy, preventing fungal 
infections, preventing STIs and supporting reproductive health needs, malaria prevention and 
others. 
2.4.3 STEP 3: ELIGIBILITY TO ART INITIATION 
With its “treat-all” recommendation, the WHO removed all limitations on eligibility for ART 
among people living with HIV; all populations and age groups are now eligible for treatment, 
including pregnant women and children (WHO, 2016: iii).  
2.4.3.1 ART Eligibility 
ART eligibility refers to the people living HIV for whom ART is indicated based on meeting 
the clinical and immunological thresholds as defined by the WHO treatment guidelines (WHO, 
2013:14). According to the WHO (2013:86) ART guidelines, not all people who were 
diagnosed with HIV were eligible for ART. This meant that once an individual had been 
diagnosed with being HIV positive, enrolment into care would allow close monitoring until the 
time an individual is deemed eligible to be initiated on ART. Accordingly, the eligibility for 
ART enrolment in Zimbabwe was until late 2016, based on a CD4 cell count equal to or less 
than 500cells/mm3 or a WHO clinical stage 3 and 4 (WHO, 2013:13) as discussed in the 
paragraphs to follow. The Zimbabwean government with the support from the United States 
Presidential Emergency Plan for AIDS Relief (PEPFAR) began implementing the Treat All 
approach in six priority districts with a national rollout following in October 2016 (PEPFAR 
Zimbabwe, 2016:6). 
2.4.3.2 CD4 Cell Count 
The CD4 lymphocytes are also called the T-helper cells are a type of white blood cells that are 
responsible for fighting germs and infection in the body making them an important part of the 
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immune system. In addition, HIV destroys the CD4 cells in the body thereby weakening the 
immune system (The Well Project, 2017). The CD4 cell count provides an indication on the 
overall immune function of an HIV-infected patient (Kumar, Kumar, Mahdi & Dhole, 2017:1) 
.CD4 cell count is a useful test that is conducted before an HIV positive person is initiated on 
ART and also used on decisions regarding screening for opportunistic infections and provision 
of prophylaxis (Meintjes et al., 2017:123). The mean normal value for most laboratories is 
approximately 500-1,300 cells/mm3. However, the WHO and national guidelines do 
recommend that PLHIV should be initiated on ART at higher CD4 counts but this is not the 
case as noticed in sub-Saharan Africa. There is sufficient evidence to the benefits of initiating 
people on ART at or below the CD4 threshold of 500cell/mm3 which include reduced mortality, 
disease progression and vertical HIV transmission (Hoffman, Van Griensven, Colebunders & 
McKellar, 2010:28). The PLHIV delay starting ART until when median CD4 cell counts is 
below 200cell/mm3 (WHO, 2015:248). This could be attributed to lack of financial resources 
and high numbers of PLHIV in this region of the world. Infrastructure for conducting CD4 
count tests is not always available especially in those low resource settings and such settings 
require the use of clinical staging for determining the level of immunocompromise (Weinberg 
& Kovarik, 2010:202).  
2.4.3.3 The WHO Clinical Staging 
The WHO developed a clinical staging system for HIV/AIDS in 1990 and later this staging 
was revised in 2007, which uses various clinical parameters to guide in the clinical decision 
making for the management of HIV/AIDS patients (WHO, 2005:2). This method has proved 
to be very useful especially in Africa where there is limited access to infrastructure for 
conducting CD4 cell count tests. The clients are categorised into one of four hierarchical 
clinical stages ranging from stage 1 (asymptomatic) to stage 4 (AIDS). In addition, patients are 
assigned to a particular stage when they demonstrate at least one clinical condition in that 
stage’s criteria (Weinberg et al., 2010:203). Patients remain at a higher stage after they recover 
from the clinical condition that placed them in that stage.  
 
 
 
Table 2.1 below shows the different stages according to the WHO and associated HIV 
symptoms. 
HIV- associated symptoms WHO Clinical Stage 
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Asymptomatic 1 
Mild symptoms 2 
Advanced symptoms 3 
Severe symptoms 4 
Source: Interim WHO Clinical Staging HIV/AIDS, 2005 
Table 2.2: WHO clinical staging of established HIV infection 
The WHO staging Description of the stages 
Stage 1: This category is assigned to a person diagnosed with HIV who is either 
asymptomatic or has generalised lymphadenopathy for longer than six 
months. 
Stage 2 This category is a mild symptomatic stage demonstrated by several 
clinical manifestations which include but not limited to an 
unexplained weight loss of less than 10% of total body weight, 
recurrent respiratory infections and a range of dermatological 
conditions. 
Stage 3 This is the moderately symptomatic category demonstrated by weight 
loss greater than 10% of total body weight, prolonged diarrhoea, 
pulmonary tuberculosis, severe bacterial infections and other 
opportunistic infections. 
Stage 4 This category is evidenced by severe symptoms that can allow 
diagnosis of AIDS to be made based on clinical findings that include 
but not limited to HIV wasting syndrome, Pneumocystis pneumonia 
and others.  
Table 2.2: The WHO staging as according to Weinberg et al. (2010:203) 
Table 2.2 above depicts the stages that are used for linkages as postulated by WHO (2005) as 
cited by Weinberg et al., (2010:203). The staging also helps in making following the criterion 
for linkage to treatment. 
2.4.3.4 Implications of “Treat All” on the ART eligibility criteria 
The third step in the treatment cascade as discussed above covers the interval from the period 
of enrolment into HIV care to the time someone is eligible to be initiated on ART. According 
to the new “treat all” approach, every person testing HIV positive is to be initiated immediately 
regardless of CD4 or WHO stage meaning that this step will cease to exist and will rather be 
combined with the second step of the treatment cascade (Fox et al., 2017:3). The implications 
of the “treat all “approach on the number of people eligible for ART is a positive one as it will 
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resultantly increase the number of asymptomatic HIV positive people accessing ART. In other 
words, by the end of 2014, approximately 1 168 451 people were eligible for ART based on 
the CD4 cell count of <500 cell/mm3 out of the 1 403 426 people living with HIV aged ≥15 
years (Takarinda et al., 2016:4). Under the “treat all” guidelines, it would mean that all the 
1 403 426 people would now be eligible for ART initiation. 
2.4.4 STEP 4: INITIATION TO LIFELONG ART 
According to the WHO (2016:75), Global ART coverage for all people living with HIV had 
reached approximately 41% – or 15 million people – by March 2015. 
2.4.4.1 Initiation and Retention on ART 
According to the MoHCC (2013:20), early treatment initiation is associated with some clinical 
and HIV prevention gains, improving survival and reducing new HIV infections at community 
level. Following the eligibility assessment for ART initiation, the next stage in the treatment 
cascade involves initiating all people living with HIV on ART. The WHO (2016:97) guidelines 
on ART recommend a fixed dose combination of first line ART for adults. This first line 
regimen is made up of Tenofovir (TDF)+ Lamivudine (3TC) + Efavirenz (EFV) which is 
commonly known Tenolam E. The Zimbabwe National ART programme has adopted the same 
first line regimen recommended by the WHO (MoHCC, 2013:28). Findings from a strategic 
timing of antiretroviral therapy (START) that was conducted at 215 sites located in 35 
countries demonstrated that early ART initiation (‘test and treat’) as compared to delayed 
awaiting certain CD4 thresholds resulted in a 53% decrease in the risk of developing AIDS-
related events and death (Koirala, Eeuba, Nampaisan, Marrone & Ekstrom, 2017: 3). Studies 
have revealed that initiating ART early has many clinical benefits. Despite the access to 
treatment reaching 12.9 million people globally by the end of 2013, only about 37% of the 
people living with HIV were receiving ART (Granich, Gupta, Hersh, Williams, Montaner, 
Young & Zuniga, 2015:2). Zimbabwe is on track towards achieving the 2020 targets for ART 
initiations as evidenced by almost 62% of all the people living with HIV receiving ART as of 
December 2015 (MoHCC, 2016:14). The number of people receiving ART is expected to 
increase with the roll out of the Treat All approach in 2016. 
2.4.4.2 Adherence 
The success of any treatment regime is dependent on the level of adherence to the therapies 
being provided (WHO, 2016:255). The WHO defines adherence to treatment as ‘the extent to 
which a person’s behaviour-taking medication, following a diet and/or executes lifestyle 
changes’ corresponds with the agreed recommendations from a health care provider (MoHCC, 
2013:23). Retention of all those initiated on ART remains a very critical part of the treatment 
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cascade (Fox et al., 2017:4). In order to attain a successful treatment outcome evidenced by 
viral suppression, ART for people living with HIV requires more than 95% adherence levels 
(Letta, Demissie, Oljira & Dessie, 2014:1). Zimbabwe has witnessed an increase in the 
retention of adults on ART over a period of 12 months as evidenced by the increase from 78% 
to 85% for the year 2012 and 2015 respectively (MoHCC, 2016:16). 
2.4.4.3 Viral Suppression 
Viral load monitoring is the gold standard for measuring adherence and monitoring treatment 
response for people on ART (WHO, 2016:258). The HIV-1 viral load is a measurement used 
to indicate the number of copies of HIV-1 Ribonucleic Acid (RNA) per millilitre of plasma. 
The plasma measurement is a very accurate reflection of the burden of infection and the 
magnitude of viral replication. It is used to assess the risk of disease progression and is critical 
in monitoring virologic response to ART (MoHCC, 2017:74). According to Takarinda et al., 
(2016: 1), prompt initiation of and adherence to ART will result in the suppression of viral load 
to undetectable levels. This brings with it individual health benefits and also prevents the 
transmission of HIV infection. There have been tremendous achievements by individual 
countries in trying to achieve viral suppression despite the world having about 13 million 
PLHIV who were not virally supressed in 2016 (UNAIDS, 2016). Countries and programmes 
have done well in trying to achieve high levels of viral suppression with Rwanda managing 
viral suppression among 83% of the clients receiving ART after 18 months of ART in 2008 to 
2009 (UNAIDS, 2014:20). According to the findings of the ZIMPHIA (2016:3), about 86.5% 
of the PLHIV who report ART use have managed to achieve viral suppression that puts 
Zimbabwe on the right course towards achieving the last 90.  
 
2.5 FACILITY LINKAGES TO HIV CARE AND TREATMENT 
A huge body of programmatic reporting exists on the loss to follow-up and mortality for 
patients who are receiving ART. However, little is known on the linkage to care and treatment 
for individuals prior to the start of ART (Krazner et al., 2010:2; Govindasamy et al., 2011:1). 
Of the studies conducted on the facility linkages to care and treatment, findings have reflected 
unacceptably low linkages. Some of these studies were conducted in sub-Saharan African 
settings with the proportion of HIV positive clients enrolled into HIV care varying from a low 
of 38% from a study in urban Zambia to 68% six months after HIV diagnosis in rural northern 
Tanzania (Kayigamba et al., 2012:1). A study conducted in Mozambique in 18 clinics found 
poor linkages between HIV diagnosis and enrolment into care (Gerdts et al., 2014: 1). Various 
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factors are associated with the loss to follow-up that can occur along the HIV treatment cascade. 
These losses can be influenced by multiple factors on the health care system, individual and 
societal level (Gerdts et al., 2014: 1). 
2.5.1 Timing for linkage to care and treatment 
Timely linkage to HIV care and treatment are key if improved outcomes are to be realised and 
this calls for CD4 cell count, HIV staging and evaluation of the client’s need for ART to be 
performed in the shortest time possible (Reddy et al., 2016:4). Studies conducted in sub-
Saharan Africa measured the average time that HIV positive clients have taken to move from 
one stage of the of the treatment cascade to the other. Findings from a facility-based registers 
review in eight Rwandan health facilities had only 42% of the clients enrolled into HIV care 
and treatment with 90 days of HIV diagnosis. In addition, of those that had enrolled in care and 
treatment within the 90-day period, 24% of them had enrolled by seven days, 37% by 30 days 
and 40% by 60 days (Kayigamba et al., 2012:4). According to the UNAIDS (2016), there is 
evidence that shows that early ART initiation has got some immunological benefits for the 
clients and the community. This was evident in studies conducted at clinics in Kigali, Rwanda, 
which saw median CD4 cell counts of people on ART initiation doubling from the figures of 
2003 to 2012 owing to the successful implementation of guidelines that enabled early ART 
initiation. Furthermore, as of mid-2016, about 78% of PLHIV in Rwanda were on receiving 
ART, and 86% of these people had managed to achieve viral suppression putting the country 
within reach of the 90-90-90 targets (UNAIDS, 2016:30). 
2.5.2 Entry Point for HIV testing vs linkage to care and treatment  
According to WHO (2016), an entry point is the opportunities or gateways that can be used to 
identify the people who can benefit from treatment through the provision of HIV testing and 
counselling. There have been studies conducted that directly focused on how the entry points 
through which HIV diagnosis was made were associated with the linkage to care and treatment 
outcomes. In a study conducted in Cape Town, South Africa, linkages to HIV care and 
treatment were found to be low despite the fact that these services are being offered for free 
within close proximity (Krazner et al., 2010:1). This study compared the linkages across 
different entry points for HIV testing at two facilities and found that the highest linkages to 
HIV care (84.1%) was among clients who had been tested through the STIs entry point while 
clients tested through the voluntary counselling and testing (VCT) had the lowest linkages 
(53.5%) (Krazner et al., 2010: 1). In terms of linkage to HIV treatment, it was highest (72.2%) 
among the clients that were tested through antenatal care (ANC) (Krazner et al., 2010: 1). 
Findings from the study conducted in Mozambique contradicted the findings of the former 
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study as it found that women diagnosed with HIV through the PMTCT were less likely to be 
linked to HIV care and treatment as compared to clients diagnosed through VCT (Gerdts et al., 
2014: 1). A cohort-based study of clients testing positive through PMTCT and VCT in 18 
health facilities was conducted in Mozambique. With regards to the HIV treatment cascade of 
testing to enrolment, enrolment to CD4 test and CD4 to ART initiation for those eligible, 
PMTCT had huge leakages of 7%, 48% and 75% respectively as compared to VCT with 3%, 
34% and 54% respectively (Gerdts et al., 2014:5). This study concluded that an increased loss 
to follow-up among women diagnosed in PMTCT relative to VCT. This then warrants further 
qualitative research to be able to establish the barriers that may be peculiar to the PMTCT entry 
point as far as linkage to HIV care and treatment is concerned. 
An extended analysis conducted on the findings of the Zimbabwe Demographic Health Survey 
(ZDHS) 2010-11 investigated factors that are associated with ever being tested in Zimbabwe. 
The study found that the odds of being tested for HIV at the facility were higher for men 
accessing services through the STI clinic while it was higher for women accessing ANC 
services (Takarinda et al., 2015). This study demonstrates the association that exists between 
the entry point for health care at the facility and the chances of HIV testing. 
2.6 CONCLUSION 
The chapter reviewed literature on the HIV epidemic at a global level and also at the regional 
and national level. The review also looked at how Zimbabwe has managed to respond as far as 
the management of HIV is concerned. This management was reviewed based on the guidelines 
that have been set by the WHO as far as the linkage to HIV care and treatment for those people 
diagnosed with HIV. Focus was made on literature on the facility-based linkages to HIV care 
and treatment. The literature on studies conducted mostly in the sub-Saharan region indicated 
that there were significantly low linkages to care and treatment following HIV diagnosis. There 
was also evidence of client loss at every stage of the HIV treatment cascade and also this being 
sometimes associated to the entry point through which the clients are diagnosed. 
The research design and methodology for this study on facility linkages to HIV care and 
treatment as per entry point at a Norton Health Centre was guided by the findings of the 
literature review. The design, methodology, study population and the processes to be employed 
for data collection and analysis and also ethical considerations will be discussed in the next 
chapter. 
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CHAPTER THREE 
                                      RESEARCH DESIGN AND METHOD 
3.1 INTRODUCTION 
 
The previous chapter focused on the literature review related to the research area. This chapter 
presents the research design and research methodology that were followed in addressing the 
research questions in the study that investigated facility linkages to HIV care and treatment as 
per entry point at a Norton Health Centre, Zimbabwe. In this chapter, there will be a 
presentation of the research design, methods used for data collection including the data 
collection instruments, study population and sampling methods used. The chapter will also 
discuss the processes that were followed in the data collection, the ethical considerations and 
the measures taken to ensure reliability and validity. The procedure for analysis of the data will 
also be presented in this chapter. 
3.2 RESEARCH DESIGN 
 
Research design is a strategy or plan of investigation that is used in order to get answers to 
research questions or problems (Kumar, 2011:95). In addition, Creswell (2014:41) describes 
research design as the type of inquiry that a researcher will use that is within the qualitative, 
quantitative or mixed methods approach that provides specific direction for procedures in a 
research design. This study followed a quantitative approach that utilised a retrospective 
descriptive research design as it was found to be the best research design that could answer the 
research question involved. The retrospective descriptive design was the most suitable design 
since the study was looking at a phenomenon of clients’ linkage to HIV care and treatment 
outcomes after being diagnosed as HIV positive through two different entry points.  
3.2.1 Retrospective Descriptive Study 
 Retrospective descriptive research involves the investigator studying a phenomenon, situation 
or a problem that has occurred in the past and formulates ideas about possible associations and 
investigates potential relationships (Kumar, 2011:110). Descriptive research involves the 
examination of the situation as it is in its current state and this can be achieved through the 
identification of attributes of a particular phenomenon based on an observational basis, or the 
exploration of correlation between two or more phenomena (Williams, 2011:66).  In order to 
have an understanding on how the entry points through which the clients were tested for HIV 
could have an association with the proportions of linkages to HIV care and treatment, there 
was need to retrospectively visit the clients’ records and make evaluations. 
29 
 
3.3 RESEARCH METHODOLOGY 
 
This study followed a quantitative research methodology. Research methodology is the 
systematic way in which the researcher intends to solve the research problem, collect the data, 
analyse, and interpret the findings (Creswell, 2009:233). The quantitative research 
methodology was used in this study. Quantitative research methodology is described as an 
approach used to answer questions about relationships among measured variables with the 
purpose of explaining, predicting and controlling phenomena. In addition, the intent of the 
methodology is to establish, confirm or validate relationships and to develop generalisations 
(de Vos, Strydom, Fouche & Delport, 2011:63). The choice to use a quantitative approach for 
this study was based on the fact that the variables under study were numerical and the 
conclusions to be made came from the calculations of associations based on the proportions of 
the linkages to HIV care and treatment from the entry points This section will also discuss the 
population, sampling and the procedures that were used to select the sample for this study. It 
also presents the data collection and analysis procedures that were followed. The research 
setting for this study will be discussed in the following paragraph. 
3.3.3 Research Setting 
 
Research setting refers to the specific place from where information for a research is gathered 
(Polit & Beck, 2012:49). This study research was conducted at Norton District Health Centre 
in a town called Norton in Zimbabwe. The decision to have the study conducted on health 
center was based on the fact of it being the largest health center in the district. This would allow 
for results that would be more representative due to the high numbers of people who access 
health services at the health center. 
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Figure 3.1: Norton location on Zimbabwe map (worldatlas.com 2017) 
Figure 3.1 shows the location of Norton on the map of Zimbabwe. Norton is a small town that 
lies about 40 kilometres west of the capital city Harare along the highway linking Harare and 
Bulawayo. It is found in Mashonaland West Province. According to the 2010 National Census, 
Norton has a population of 67 591 people. The hospital falls under the administration of the 
Norton Town Council Department of Health. This hospital was chosen because it is the biggest 
health facility in the area.  
3.3.1 Population 
 
A population is the entire aggregation of cases in which a researcher is interested (Polit & Beck, 
2012:273). It is common practice in descriptive studies to define the study population first and 
then make observations on the sample taken from it (Banerjee & Chaudhury, 2011).  The study 
population were the records of clients who tested HIV positive between January 2016 and 
December 2016 through the two entry points for HIV testing and counselling at a Norton Health 
Centre. These entry points are the Outpatients Department (OPD) and Wards entry point and 
the Prevention of Mother to Child Transmission (PMTCT). The population for this study was 
approximately 504 client records. The OPD and Wards entry point provides HIV testing for 
the clients that come to the facility through the out patients’ department and also to those 
patients admitted in the various wards at the hospital. The PMTCT entry point provides HIV 
testing to clients coming for antenatal care, maternity and postnatal care. In order for the 
records to be included in the study, the client had to meet the following criteria. 
Inclusion criteria: Clients of 16 years and above testing HIV positive for the first time at the 
Norton Health Centre between January 2016 to December 2016. The decision of having the 
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age limit at 16 years was to conform with the Ministry of Health and Child Care’s consent age 
for HIV testing services, which is 16 years or older (MoHCC, 2017:34).  
Exclusion criteria: Clients under the age of 16 years testing positive. Clients with an already 
known HIV positive status were also excluded from the study. The study also excluded clients 
who had documented evidence of having been tested before the study period with known HIV 
diagnosis. 
3.3.2 Sample and Sampling 
 
Kumar (2011:176) defines sampling as the process of selecting study units from a defined study 
population in order to make an inference about the whole population. In this study, 
proportionate stratified probability sampling was used. According to Polit and Beck 
(2017:740), probability sampling is defined as the selection of sampling elements from a 
population using a random procedure. Stratified probability sampling involves dividing the 
population into two or more homogenous subsets from which an appropriate number of 
elements are selected through random processes (Polit & Beck, 2012:281). Proportionate 
stratified probability sampling as defined by Kumar (2011:185) as sampling in which elements 
are selected in proportion to the size of the stratum in the population. The population was 
subdivided into three strata based on the entry point for HIV testing with the sample size for 
each entry point based on the proportion it contributed to the population size.  
The minimum sample size was calculated using the Raosoft Software (Raosoft, 2016). The 
formula takes into account of the confidence level, margin of error and the population size to 
be used in the study. The confidence level for this study was set at 95% and the margin of error 
was 5% and the population size was approximately 504 client records. The minimum sample 
size calculated for this population was approximately 219 records. Furthermore, the researcher 
decided to increase the sample size from the minimum value of approximately 219 to 
approximately 242 to cater for some of the records that could be dropped out owing to some 
failing to meet the requirements.  The formula that was used to determine the sample size is as 
follows: 
x=Z(c/100)2 r (100-r) 
n=N x/ ((N-1)E2 + x)                          E=Sqrt[(N - n)x/n(N-1)] 
A simple random sampling procedure was applied to the stratified populations using computer 
software. Polit and Beck (2012:280) define simple random sampling as the approach in which 
the researcher establishes a sampling frame from which the sample will be chosen. The 
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sampling frame in this research was all the adults who tested HIV positive between January 
2016 to December 2016 at Norton Health Centre. Table 3.1 below shows the proportionate 
stratified sampling outcomes for the entry points involved in the research. 
Entry Point HTC Positive Proportion Sample size 
OPD and Wards 381 75.56% 183 
PMTCT 123 24.40% 59 
Total Population 504 100% 242 
Table 3.1. Sampling table for the entry points for HIV Testing and Counselling (Researcher made, 2017)  
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3.3.4 Data Collection 
 
The data collection process involves gathering and measuring information on variables of 
interest in an established systematic fashion that allows the researcher to test the stated 
hypotheses, and evaluate outcomes (Polit & Beck, 2017:725). The data for this study were 
collected from Norton District Health Centre using the records of the clients who tested HIV 
positive between January and December 2016. The data collection involved retrospectively 
tracing clients’ records that tested HIV positive between January 2016 and December 2016 at 
the Norton Health Centre to determine documented uptake of subsequent HIV care and 
treatment services.  
The data for this study were obtained from the HIV treatment services records which are the 
HIV Testing and Counselling (HTC) register, Pre-ART register and the ART register from the 
three entry points that provide HIV testing and counselling which are the combined OPD and 
Wards entry point and PMTCT entry point. The electronic patient management system (ePMS) 
and Opportunistic Infections/Antiretroviral therapy (OI/ART) patient care booklets were also 
used to trace some of the individual care and treatment outcomes.  
3.3.4.1 Data Collection Instrument 
 
When conducting quantitative research, it is very critical to have accurate and systematic data 
collection mechanisms in place (Abawi, 2014:2). To collect this data various research designs, 
call for different data collection instruments that are the tools that are used in collecting data in 
a study. Data collection for this study was done using a self-designed checklist (Annexure E).  
A checklist is an instrument observer use to record observed phenomenon (Polit & Beck, 
2012:315). A checklist helps in extracting data in a useful manner and is mostly used in 
evaluating databases and collecting data on occurrences of incidents, events, tasks or problems 
and also provides room for documenting other observed comments (Action-Based Research, 
2017).  
 
The checklist developed was guided by the research objectives and had sections meant at 
collecting, demographic information, clinical, and medical information of the sampled records. 
The following paragraphs discuss the sections in the checklist (Annexure E).  
 
SECTIONS 1, 2 and 3: These sections collected the demographic information of the clients 
and the entry point through which HIV testing was conducted. For those clients that managed 
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to get enrolled either in Pre-ART or ART care, the OI/ART numbers were also documented. 
The client’s initials, age and gender were also documented. The client initials have been 
documented so that they can be used by the facility should they decide to make follow-ups on 
clients that have not been linked to care and treatment. The initials were not captured during 
the data capturing for analysis. 
 
SECTION 4, 5 and 6: These sections collected data that is related to the linkage to HIV care 
for the clients. This information included documentation of client in Pre-ART register, CD 4 
test information and WHO clinical staging results (Chapter 1, Section 1.1). 
 
SECTION 7 and 8: Information on the linkage to HIV treatment was documented in this 
section. The sections collected information on the ART initiation outcomes and the source of 
information used to verify this information. 
 
SECTION 9: This section was used to document any relevant observations that would have 
been made for all the clients that had no documented evidence of being initiated on ART. 
 
3.3.4.2 Data Collection Procedure 
 
The data collection procedure included initially retrieving the records of all clients that tested 
HIV positive during the research period and then drawing the required sample from the three 
entry points. The clients’ demographic data and clinical information on linkage to HIV care 
and treatment were retrieved from the HTS registers, individual client OI/ART booklets and 
the ePMS. The information was then transcribed from these sources to the self-designed 
checklist (Annexure E) by the researcher aided by trained enumerators. 
3.3.5 Data Analysis 
 
Data analysis involves the systematic organisation and synthesis of research data and in 
quantitative data, the testing of hypothesis using the data (Polit & Beck, 2017: 725). Data 
collection for this research was conducted in August 2017 looking at 242 client records. The 
data were then analysed using Epi Info version 7 Statistical Software (Centre for Disease 
Control and Prevention, Atlanta, GA). Although the researcher was knowledgeable in the 
process of data analysis using the above-mentioned statistical package, a neutral statistician 
was involved in the validation of the process and results. 
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3.3.4.3 Ethical Considerations  
 
Research ethics govern the standards of conduct of scientific research with the aim of 
protecting the dignity, rights and welfare of the research participants. An ethics committee 
ensured that appropriate ethical standards are being upheld, especially if research involves 
human participants (WHO, 2017). To comply with the ethical requirements for the study, 
ethical clearance to conduct the research was obtained from the University of South Africa 
Higher Degrees Research and Ethics Committee (Appendix A) to conduct the research and 
also from the Medical Research Council of Zimbabwe (Annexure C). The Norton Town 
Council Department of Health also granted permission for the study to be conducted at Norton 
Hospital (Annexure D). 
There are three core ethical principles in research that involves human respondents whether 
directly or indirectly, namely, beneficence, respect for human dignity and justice (Polit & Beck, 
2012:152). The principle of beneficence imposes the responsibility on researchers to make sure 
that research conducted minimises harm and maximises the benefits on the research 
participants (Polit & Beck, 2012:152; Joubert, Ehrlich, Katzenellenbogen & Karim, 2007:33). 
In line with this principle, the process of data collection involved reviewing the client’s medical 
records at the facility without any direct interaction with the clients. However, this method of 
data collection did not expose the participants to any form of physical or emotional harm. The 
health benefit of this exercise lies in the fact that all the findings of this research will be used 
by the health facility to develop means of enrolling to care and treatment those clients that will 
have been found not to be in care. 
 
Respect for human dignity calls for all human beings participating in research to be treated as 
autonomous agents capable of controlling their actions and hence should be accorded the right 
to self-determination and the right to full disclosure (Polit & Beck, 2012:154). The research 
involved accessing the clients’ records that have the names and contact details which in itself 
had a potential of violating the clients’ privacy. In order to protect the privacy of the clients 
that had their records used in the study, no individual client identifiers were included in the 
data analysis and reporting of findings at all. Because of this absence of the individual client 
identifiers for the records that were used, the researcher found it appropriate not to seek 
individual consent from the clients. The data collection instruments used in this study were 
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always kept in a secured place and the only people that had access to them are those that were 
directly involved in the study.  
 
The principle of justice entails that all study participants should be treated fairly in terms of the 
benefits or risks that might arise from the research. In addition, participant selection should be 
made on the research requirements and not vulnerability (Polit & Beck, 2012:155). The 
selection of the participants was made purely on the requirement of HIV positive outcome for 
clients tested between January 2016 to December 2016. The selection of the client records that 
were used for the study was conducted through random sampling to avoid prejudice any client’s 
records from being included in the study. More importantly, the researcher did not hold back 
any information from the Norton Health Centre Management and shared the findings of the 
research with them. 
3.4 MEASURES TO ENSURE RELIABILITY AND VALIDITY 
 
3.4.1 Reliability 
 
The reliability of a quantitative instrument is a major criterion used to assess the quality of the 
instrument (Polit & Beck, 2012:331). Reliability of a research instrument in quantitative 
research is the extent to which the same results can consistently be obtained upon using the 
instrument in the same situation on repeated occasions (Heale & Twycross, 2015:66). In 
addition, reliability can be assessed through three types of validity, namely, stability, internal 
consistency and equivalence that are commonly used to evaluate it. Reliability of the checklist 
to be used in this study was evaluated for equivalence. Equivalence is the degree of consistency 
in providing measurements of the same attributes and is of concern when different observers 
are using the same instrument to collect data at the same time (Brockopp & Hastings-Tolsma, 
2003:217).  The second major criterion for evaluating an instrument is its validity (Polit & 
Beck, 2012:336). 
3.4.2 Validity 
 
Validity is the ability of an instrument to measure what is designed to measure (Kumar, 
2011:166). Unlike in reliability, the validity of a research instrument is difficult to evaluate 
(Polit & Beck, 2012:336). There are different kinds of validity that can be used to assess a 
given instrument for validity. The instrument used in this study was a checklist and it was 
assessed for validity based on content validity and construct validity and face validity. 
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3.4.2.1 Content validity 
 
Content validity looks at whether the instrument adequately covers almost all the content it 
should cover with respect to the variables under study, namely, linkage to HIV care and 
treatment (Heale et al, 2015:66). In this research, the checklist used was designed based on the 
HIV continuum of care such that it captures elements from the diagnosis of HIV to the point 
of initiation on ART. 
3.4.2.2 Construct validity 
 
Construct validity is the extent to which inferences can be drawn about test scores in relation 
to the concept being studied (Heale & Twycross, 2015:66), in this case linkages to HIV care 
and treatment. This is a key criterion as it helps to have an understanding of exactly what the 
instrument is really measuring (Polit & Beck, 2012:339). It is the extent to which the checklist 
to be used is measuring the linkages to care and treatment and this will be ensured through 
homogeneity in all the elements of the checklist. Linkage to HIV care was determined by the 
client accessing CD4 test and WHO clinical staging. These would then determine the eligibility 
of a client for linkage to HIV treatment, which was determined by the outcome for ART 
initiation. The checklist was valid as it only measured the outcomes for linkages to HIV care 
and treatment for the clients that were diagnosed through the three entry points. 
3.4.2.3 Face validity 
 
Polit and Beck (2012:336) define face validity as the extent to which an instrument looks like 
it is measuring the target construct.  A test in which most people would agree that the test 
items appear to measure what the test is intended to measure would have strong face validity 
(Taderhoost, 2016:29). Face validity about the self-designed checklist used in this study would 
be to evaluate how much the instrument measured attributes related to linkage to HIV care and 
treatment after an HIV diagnosis. However, the enumerators who assisted the researcher did 
not experience any challenges in interpreting the requirements of the various sections of the 
checklist. This response from the users of the instrument can be used to demonstrate the face 
validity of the instrument. 
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3.5 CONCLUSION 
 
 Figure 3.1 below shows a diagrammatic flow summary of the research design and research 
methodology that was used in the study. This chapter covered the research design, research 
methodology with focus on the research population, sample and the sampling procedures, data 
collection and analysis that were used in the study. Ethical considerations that were made for 
the study were discussed including the measures that were taken to ensure that all the processes 
were compliant with the ethical requirements. The chapter also discussed on how the issues of 
reliability and validity for the data collection instrument would be ascertained. The following 
chapter discusses the presentation of the study findings through the analysed data in detail. 
Interpretations and description of the findings from that analysis ofthedataarealsoprovided.   
 
Figure 3.2: The research methodology flow summary for the study (researcher made, 
2017) 
 
 
                       
                                 
                                                                      CHAPTER FOUR 
    ANALYSIS, PRESENTATION AND DESCRIPTION OF RESEARCH FINDINGS  
 
Research Design • Descriptive
Research Method • Quantitative
Time • Retrospective
Unit of analysis • Individual client record
Measurement 
instrument
• Self-designed checklist
Sampling • Stratified proportionate probability sampling
Data analysis • Epi Info 7 Statististical Package
39 
 
4.0 INTRODUCTION 
The previous chapter focused on the research design and research methodology that was used 
in collection of the data. The researcher collected the data with the assistance from 3 trained 
enumerators, 1 male and 3 female enumerators. The instrument used for the data collection was 
a self-designed checklist. The sample size was calculated using the Raosoft Sample calculator 
(refer to Chapter Three). The client records used for the sample were drawn using a stratified 
proportionate probability sampling approach. The data collection for this study was done in 
August 2017. The data collected was transferred from the self-designed checklist to an 
electronic database on the Epi Info 7 Statistical Package. This chapter presents and describes 
the findings of the study. The aim of this study was to determine the proportion between the 
linkages to HIV care and treatment as per entry point for the people diagnosed with HIV at a 
Norton Health facility to make recommendations to improve linkage per entry point. The 
researcher used a quantitative, retrospective descriptive research design. The results were 
presented in the form of frequency distribution, graphs and charts, and measures of central 
tendency. The findings of the study were presented in the sequential order of the HIV treatment 
cascade at the Norton Health Centre as presented in Chapter One. Findings were presented 
under the HIV diagnosis, linkage to HIV care and linkage to HIV treatment. 
4.1 DEMOGRAPHIC DATA 
Demographic data is the statistical data of a population, especially those showing average age, 
income, education, of or relating to demography, the science of vital and social statistics 
(Dictionary.com, 2017). The demographic data of this study are described in the paragraphs 
that follow and will include age, gender and entry point. Obviously, clients at this health centre 
are all Zimbabweans based on the geographical region. 
4.1.2 HIV prevalence at Norton Health care centre 
A total of 242 of the HIV positive client records who met the inclusion criteria from January 
2016 to December 2016 for this research were reviewed. About three (1%) of the records were 
excluded from the study as it was noticed that the clients were already known HIV positive 
clients at the time they tested during the period of study. Of the approximately 239 (100%) 
remaining records, 183(77%) of the clients were diagnosed through the OPD and Wards entry 
point and 56(23%) diagnosed through the PMTCT entry point.  
The OPD and Wards entry point had a higher proportion of the client records that were used in 
this research than the PMTCT entry point owing to the high volumes of clients that are seen in 
the OPD and the wards at the hospital as compared to the number of clients that access PMTCT 
services annually. This finding is consistent with the study that conducted in Cape Town by 
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Kranzer et al., (2010:3) which had about 1990 clients diagnosed as HIV positive with only 320 
(16%) of the clients diagnosed through the antenatal clinic (ANC) and about 1670 (84%) 
diagnosed through STI, TB and VCT entry points. The ANC entry point in this study is 
equivalent to the PMTCT entry point and the combined STI, TB and VCT are equivalent to the 
OPD and Wards entry point. 
Of the 239 (100%) clients diagnosed in the year 2016, about 143(60%) had documented 
evidence of initiation on ART while about 96 (40%) had no documented evidence of initiation 
on ART. 
 
                                              Figure 4.1: ART initiation pie chart 
As evidenced by the ART initiation pie chart in Figure 4.1 above, there was a low proportion 
of diagnosed clients that were initiated on ART. Linkage to HIV treatment will be discussed in 
more detail in the section 4.3 to follow in this chapter. 
4.1.3 Gender distribution 
Understanding gender norms and gender inequalities is essential in reducing the risks for HIV 
transmission among men and women. Although there are similarities in HIV risk factors and 
behaviours across genders, differences exist and some gender groups are far more affected than 
others (CDC, 2017).  
  
60%
40%
Antiretroviral Therapy Initiation 
Initiated on ART Not initiated on ART
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Table 4.1 Gender distribution  
Client's gender Frequency Percent 
Male 107 44.77% 
Female 132 55.23% 
TOTAL 239 100.00% 
 
Table 4.1 above shows that more females 132(55%) were diagnosed with HIV than the males 
107(45%) during the study period. The higher number of females that were diagnosed as HIV 
positive than males can be attributed to the relatively higher proportion of women (80%) who 
access HIV testing services than men (62%) in Zimbabwe (ZDHS, 2015:243). ZIMPHIA 
(2017:1) also reported an annual HIV incidence rate in Zimbabwe of about 0.59% among 
females and 0.31% among males. Therefore, there is a need for the health centre to further 
investigate the reasons that may be behind the low uptake of HIV testing by men at the centre. 
In addition, there is also a need to develop interventions that are targeted at increasing the 
number of males who access HIV testing services as indicated in the differentiated HIV care 
model, which recommends for a client centred approach in the provision of HIV services 
(MoHCC, 2017:35). 
  
4.1.4 Age Distribution 
The data for the study were collected from records of clients that were 16 years and above 
between January to December 2016. The decision of having the age limit at 16 years was to 
conform to the Ministry of Health and Child Care’s consent age for HIV testing services, which 
is 16 years or older (MoHCC, 2017:34).  
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                                    Figure 4.2: Histogram of age distribution 
The median age [Interquartile range (IQR)] of the clients that were diagnosed with HIV was 
32 years [26-39 years]. Figure 4.2 above shows the proportions of HIV positive clients by age 
group. The 25-29 years age group had the highest number of clients 56(23%) testing HIV 
positive followed by the 30-34 years age group 48(20%) and the 35-39 years age group 36 
(15%). The lowest number of client records with an HIV positive result was among the 60 
years and older age group 3 (1%).   
The majority of the clients 207(87%) were from the 20-49 years age group and of these clients, 
about 111(54%) were females and about 96(46%) were males. This represents higher HIV 
incident rates among females. Similarly, this finding correlate with the UNAIDS (2017:2) 
report that in 2015, women accounted for 50% of the people living with HIV in East and 
Southern Africa. Kapiamba et al., (2016:197) also reported that the 20-49 years’ age group 
made up the majority 57 (93.4%) of the participants that were HIV positive in a study 
conducted in KwaZulu-Natal Province of South Africa.  
Of concern was the relative low numbers of client records that were recorded in the 16-19 years 
and 20-24 years’ age groups of approximately 13 (5%) and 28 (12%) respectively. The 
UNAIDS (2015:8) reports that HIV remains particularly devastating for adolescents and young 
adults aged 15–24 years who account for approximately 50% of all new HIV infections and 
33% of persons living with HIV/AIDS worldwide. 
4.1.5 Entry point for HIV testing 
As described in Chapter One, entry point for this study is the gateway through which people 
can receive HIV testing and treatment services at the health centre.  These include Outpatients 
Department (OPD) and prevention of mother to child transmission (PMTCT) entry point. 
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                                       Figure 4.3: HIV diagnosis by entry point 
Figure 4.3 above shows a pie chart of the client records diagnosed with HIV through the two 
entry points at the health centre. Majority of the clients 180(75%) were diagnosed through the 
entry point that caters for OPD and Wards while 59 (25%) were diagnosed through the entry 
point for PMTCT of HIV. Of the 180 clients diagnosed at the OPD and Wards entry point, 
94(52%) were males and 86(48%) were females which represents an almost balanced 
proportion in terms of gender. There were more females 46(78%) than males 13(22%) who 
were diagnosed through the PMTCT entry point. This is because the PMTCT entry point 
mainly caters for females accessing the health centre for antenatal, maternity and post-natal 
care. The males who were tested in the PMTCT entry were mainly those accompanying their 
spouses for antenatal care. The Ministry of Health and Child care of Zimbabwe recommends 
for couple HIV testing during antenatal care as a way of eliminating mother to child to 
transmission of HIV (MoHCC, 2017:33).  
4.2 ENROLMENT TO HIV CARE 
Enrolment to HIV care is the second step in the HIV treatment cascade and it has been 
described as the ‘Achilles heel’ of the treatment cascade (Labhardt et al., 2016:2). According 
to WHO (2013:86), it is very important for all people living with HIV to enrol into care as soon 
as possible to facilitate early assessment for ART eligibility and timely ART initiation. In this 
study, linkage to HIV care referred to the first documented attendance for CD4 or the WHO 
clinical staging after a positive HIV diagnosis. The linkage to HIV care was presented in the 
following sections in terms of the gender of the clients and entry point for HIV diagnosis. 
75%
25%
HIV Diagnosis by entry point
OPD + Wards
PMTCT
44 
 
4.2.1 Linkage to HIV care by gender 
Out of the 239 client records that had a documented HIV positive result during the study period, 
about 144(60%) had documented evidence of being linked to HIV care. Conversely,   95 (40%) 
of the client records had no documented evidence of linkage to HIV care. Figure 4.3 below 
shows the stacked column for linkage to HIV care by gender. Among the 144 clients that had 
documented evidence for linkage to HIV care, there was a higher proportion of females as 
compared to males, 87 (66 %) vs 57 (53%) respectively. However, the difference in the 
proportions is not significant at a 95% confidence interval, p=0.062 for the period January 2016 
to December 2016. 
                             
                                            Figure 4.3: Linkage to HIV care by gender 
 
4.2.2 Evidence linkage to HIV care by entry point 
Figure 4.4 shows the proportions of linkage to HIV care based on the entry point from which 
the clients were diagnosed with HIV. The entry point that had the highest number of client 
records with evidence for linkage to HIV care was the PMTCT that had about 50(85%) linked 
to HIV care and 9 (15%) not linked to HIV care. The OPD and Wards entry point had the 
lowest proportion of clients linked to HIV care of about 94(52%) while 86(48%) of the clients 
not having evidence for linkage to HIV care. There was a statistically significant variation in 
proportions of clients with documented evidence of linkage to HIV care between entry points 
(p=0.00002) at 95% confidence interval.  
 
This finding contradicts a study in Mozambique that found clients diagnosed with HIV through 
the PMTCT centre were less likely to be linked to HIV care and treatment as compared to 
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clients diagnosed through the voluntary counselling and testing (VCT) centre (Gerdts et al., 
2014:1). The same contradictory finding was reported in a study carried out in Cape Town by 
Kranzer et al., (2010:3) where patients diagnosed with HIV early through the antenatal care 
were less likely to link to HIV care. 
                           
                                          Figure 4.4: Linkage to HIV care by entry point 
4.2.3 ART eligibility  
ART eligibility refers to the people living HIV for whom ART is indicated based on meeting 
the clinical and immunological thresholds as defined by the WHO treatment guidelines (WHO, 
2013:14). The eligibility for ART enrolment in Zimbabwe was until late 2016, based on a CD4 
cell count equal to or less than 500 cells/mm3 or a WHO clinical stage 3 and 4 (WHO, 2013:13) 
4.2.3.1 CD4 Cell Count 
A baseline CD4 cell count for a newly HIV diagnosed individual serves as a significant 
prognostic indicator for treatment outcome (Hoffmann et al., 2010: 29). Of the 239 clients’ 
records diagnosed with HIV, about 119 (50%) of the clients had a documented CD4 test done 
while the other 120 (50%) had no documentation of a CD4 test having been done. The median 
for the CD4 test results was 523 cell/mm3 [240-867 cell/mm3], which is an indication that the 
clients would have a better treatment prognosis. This median CD4 cell count was higher for 
the clients that enrolled into care when compared to some median CD4 cell counts from a study 
that were conducted in Rwanda by Kayigamba et al, (2012:242) with median of 387. According 
to the WHO 2013 guidelines for ART initiation based on a CD4 cell count of 500 cell/mm3 or 
below, about 59 (50%) of the clients that had a CD4 cell count result were eligible for ART 
initiation and about 60(50%) would not been eligible for initiation at the time of HIV diagnosis.  
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4.2.3.2 The WHO clinical staging 
The WHO has four staging system used for clients diagnosed with HIV to add on the clients 
are categorised into one of four hierarchical clinical stages ranging from stage 1 
(asymptomatic) to stage 4 (AIDS) (Weinberg et al., 2010:203). Table 4.2 below shows the 
frequency distribution for WHO clinical staging results for the clients that had documented 
evidence for the WHO clinical staging. 
WHO stage Frequency Percent 
Stage 1 39 27.86% 
Stage 2 71 50.71% 
Stage 3 30 21.43% 
Stage 4 0 0% 
TOTAL 140 100.00% 
Table 4.2: The WHO clinical staging frequency distribution 
About 140 (59%) of the clients had documented evidence of having gone through the WHO 
clinical staging while 99 (41%) had no evidence of having done the clinical staging. The 
majority of the clients 71 (51%) were documented to be in WHO stage 2. This stage is a mild 
symptomatic stage demonstrated by several clinical manifestations, which include but not 
limited to an unexplained weight loss of less than 10% of total body weight, recurrent 
respiratory infections and a range of dermatological conditions (Weinberg et al., 2010:203). 
There were no clients that were documented to have a stage 4 outcome. Of the clients who 
received the staging 140 (100%), about 30 (21%) of the clients were eligible for ART initiation 
at the time of HIV diagnosis based on the WHO clinical stage 3 or 4 according to the WHO 
(2013) guidelines. Following the eligibility assessment for ART initiation, the next step in the 
treatment cascade involves initiating all people living with HIV on antiretroviral therapy. 
4.3 LINKAGE TO HIV TREATMENT: ART INITIATION 
Linkage to HIV treatment in this research was defined in Chapter One as documented initiation 
on ART following HIV diagnosis. The Ministry of Health and Child Care in Zimbabwe 
recommends early treatment initiation as it is believed to be associated with some clinical and 
HIV prevention gains, improving survival and reducing new HIV infections at community level 
(MoHCC, 2013:20). 
 
 
4.3.1 Linkage to HIV treatment by gender 
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                                    Figure 4.5: Linkage to HIV treatment by gender 
Figure 4.5 above shows the bar graph of the variation in proportions for linkage to HIV 
treatment between gender. There is a higher proportion of females (66%) who had documented 
evidence of having been linked to HIV treatment than for males (52%). The difference in the 
proportions between linkage to treatment for females and males is statistically significant at a 
95% confidence interval (p=0.046). WHO (2016:9) has also reported the high proportion of 
females than males initiating on ART after an HIV diagnosis, where only 40% of the males 
around the world living with HIV access treatment. In addition, this low ART initiation among 
the males stem from the fact that few males get access to HIV testing with only 30% of HIV 
tests done globally having being done on males. 
4.3.2 Linkage to HIV treatment by entry point 
Clients at the Norton Health Centre are initiated on ART through the opportunistic infections 
(OI) clinic. The OI clinic receives clients that will have been diagnosed with HIV through the 
OPD and Wards and the PMTCT entry points. 
                           
                                  Figure 4.6 Linkage to HIV treatment by entry point 
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Figure 4.6 shows the linkage to HIV treatment outcomes between entry points of HIV 
diagnosis. The OPD and Wards entry point had approximately 93 (52%) client records with 
documented evidence of ART initiation while about 87 (48%) client records had no evidence 
of ART initiation. For the clients diagnosed with HIV through the PMTCT entry point, about 
50 (85%) had documented evidence of ART initiation while approximately 9 (15%) had no 
evidence of ART initiation. There was a statistically significant variation in the proportions of 
clients that had documented evidence of linkage to HIV treatment between the two entry points 
(p<0.05) at a 95% confidence interval. These findings contradict the Gerdts et al.’s (2014:5) 
study that found that clients that were diagnosed through the PMTCT centres were less likely 
to initiate on ART when compared with patients diagnosed through VCT centres.  
4.4 The HIV treatment cascade for Norton Health Centre 
 
Figure 4.6: HIV treatment cascade for the Norton Health Centre 
Figure 4.6 above shows the HIV treatment cascade for the client records that were used in the 
research. The treatment cascade describes the progression of people living with HIV (PLHIV) 
through HIV testing and counselling, access to and linkage to care, eligibility assessment and 
clinical staging for ART, pre-ART care, ART initiation and lifelong ART adherence and 
retention in care (Layer et al., 2014:8). Proportionally, 60% (n=144) of the 239 client records 
had documented evidence of linkage to HIV care evidenced by a CD4 test done or WHO 
clinical staging. Of the 144 clients linked to care, 99% (n=143) client records had documented 
linkage to HIV treatment evidenced by documented ART initiation. The linkage loss can be 
defined as the missed opportunities for linkage to HIV care and treatment for clients diagnosed 
with HIV. The highest linkage loss 40% occurred between the diagnosis of the clients and the 
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enrolment into HIV care with almost no linkage loss 1% from those clients that had been linked 
to HIV care. 
 
 This finding is in line with the findings of a previous study that has been conducted in Durban 
which found that there were significant losses between HIV testing and enrolment into care for 
clients who tested HIV positive from all the entry points involved in the study (Losina et al., 
2010:7).  More importantly, the 99% ART initiation rate is evidence that had all the clients 
been enrolled in care, there would be a high chance of having them also initiated on ART. Any 
intervention that is going to be crafted by the Norton health facility should pay special attention 
in ensuring that all the clients that are diagnosed with HIV at the health centre are retained in 
care so that they will be able to fully benefit from the HIV treatment package.  
4.5 CONCLUSION 
This chapter presented and described the findings of the study. The findings of the study were 
presented in terms of the demographic characteristics of the client records that were reviewed. 
The presentation was structured to follow the steps in the HIV treatment cascade of HIV 
diagnosis, linkage to HIV care and finally linkage to HIV treatment. It was reported that the 
overall proportion of clients with documented linkage to HIV treatment for the period of the 
study was 60%.  The chapter presented the proportions for HIV diagnosis, linkage to HIV care 
and treatment. Furthermore, the variations in proportions between the two entry points and also 
between the gender were evaluated at every level and determinations of statistical significance 
were made. The findings from this study were also compared with findings form similar studies 
that have been conducted in order to establish any similarities and contradictions. The next 
chapter discusses the recommendations that have arisen from the findings of this study. The 
limitations that were faced during the study and also the conclusions that were arrived at will 
also be discussed. 
 
                                                       CHAPTER FIVE  
 
              CONCLUSIONS, LIMITATIONS AND RECOMMENDATIONS 
5.1 INTRODUCTION 
The previous chapter presented and discussed the findings of the study and compared it with 
other related studies that have been conducted in the past. A brief summary of the research 
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design and method utilised in conducting the study will be presented. The findings from 
Chapter Four will be used to answer the hypotheses proposed in Chapter One. This chapter will 
also look at the recommendations in light of the findings of the study. This chapter will discuss 
the conclusion that was arrived at based on the findings from the analysis of the data. Any 
limitations that were faced in conducting the study will also be discussed. The aim of this study 
was to determine the proportions of linkages to HIV care and treatment as per entry point for 
the people diagnosed with HIV at a Norton Health Centre. The study also sought to make 
recommendations to improve linkages to HIV care and treatment per entry point where there 
is a need. This study identified the proportions of clients enrolled at every stage of the HIV 
continuum of care for people diagnosed with HIV at a Norton Health Centre. The study also 
identified the any losses in the linkages to care and treatment as per entry point. This can be 
useful in addressing   any bottlenecks in some of the entry points. The research findings from 
Chapter Four will help to test the following hypotheses that were formulated for this study. 
They are as follows: 
• H1: There is a significant relationship between the entry point from which people are 
diagnosed with HIV at the facility and the linkage to HIV care and treatment outcome. 
• H2: There are more HIV positive females linked to HIV care and treatment than HIV 
positive males at the health facility. 
The research design and methods that were used are summarised in the section below. 
5.2 RESEARCH DESIGN AND METHOD 
A quantitative, retrospective, descriptive research design was used to conduct the study at a 
Norton Health Centre, in the Mashonaland West Province of Zimbabwe. A self-designed 
checklist was used to collect data from the clients’ records. Data were collected regarding 
demographic information, HIV diagnosis at the two HIV testing entry points and the outcomes 
as far as being enrolled HIV care and ART initiation is concerned. The information was 
collected from the health centre’s HIV testing services registers for the clients that had been 
diagnosed between January 2016 and December 2016. 
 
The client records that were used came from the OPD and Wards and the PMTCT entry points. 
A total of 504 records were meeting the inclusion criteria and selection of the 242 client records 
that were used was selected through stratified proportionate random sampling. The records 
were stratified by the entry point from which the client would have been diagnosed with HIV 
and proportionate representation had to be factored in too. The sample comprised 183 client 
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records from the OPD and Wards entry point and 59 client records from the PMTCT entry 
point. Data collection was done in the period between August 2017 and October 2017. The 
data that were retrieved from this randomly selected sample was analysed using the Epi Info 7 
Statistical Package and the findings of the analysis were presented in detail in Chapter four. A 
qualified statistician validated the results from the data analysis and the findings are discussed 
in the following section. 
5.3 SUMMARY AND INTERPRETATION OF RESEARCH FINDINGS 
This section will discuss the findings of the analysed data from the study conducted at a Norton 
Health Centre. The aim of the study was to determine the proportions of clients’ records that 
had documented evidence of linkage to HIV care and treatment as per entry point following an 
HIV diagnosis for the period January 2016 to December 2016. The determinant for ART 
eligibility for the clients that were diagnosed with HIV at Norton Health Centre was based on 
the WHO (2013) guidelines for initiating ART at the time the concept for the study was 
developed in 2016. The WHO (2013) guidelines recommended that ART should be given to 
all people diagnosed with HIV with a CD4 cell count of less than or equal to 500 cells/mm3 or 
a WHO clinical staging of 3 and 4 in places where CD4 cell tests are not available (MoHCC, 
2013:13). Accordingly, the Ministry of Health and Child Care adopted the WHO (2015) 
guidelines for ART initiation in the beginning of the year 2017 which are referred to as the 
“Treat All” approach. The “Treat All” approach recommends initiation of ART to all adults 
living with HIV regardless of the WHO clinical stage and at any level of CD4 cell count (WHO, 
2016:74). Under these new guidelines, all the client records that were sampled were eligible 
for ART initiation. 
 
It was observed that there were more females 132(55%) who were documented to have been 
diagnosed with HIV than the males 107(45%) during the study period. This finding confirms 
the gendered vulnerability that females are exposed and vulnerable regarding the risk of HIV 
infection. The ZDHS (2015:276) found the HIV prevalence to be higher (16.7) among females 
aged 15-49 years than males (10.5%) of the same age group. The higher number of females 
diagnosed with HIV at the health centre might not be necessarily all because of the high 
infection rates in females. It could also have been attributed to by the low number of males 
who generally get tested for HIV which in turn will reduce the HIV positivity yield for the male 
gender during the study period. The WHO (2016:6) reports that males account for 
approximately 30% of the HIV tests that are conducted globally in year. 
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The median age for the clients’ records that were reviewed during the study period was 32 
years [26-39 years]. The 25-29 years age group had the highest number of clients 56(23%) and 
the lowest number of client records was in the 60 years and older age group (15%). The 20-49 
years age group had the highest number 207(87%) of client that were diagnosed with HIV 
comprised of about 111(54%) females and about 96(46%) males. These findings reflect higher 
infection rates among the 20-49 years age group with the gender disparity discussed in the 
paragraph above also being demonstrated. Of concern was the relative low numbers of client 
records that were recorded in the 16-19 years and 20-24 years’ age groups of approximately 13 
(5%) and 28 (12%) respectively. These age groups make up the part of the adolescents and 
young adults that contributed to almost 3.9 million people who were living with HIV in 2014 
(UNAIDS, 2015). 
 
The data that were analysed in the study came from the points for HIV testing at the health 
centre which were the OPD and Wards entry point and the PMTCT entry points. A higher 
number of the client records 180(75%) reviewed were tested for HIV from the OPD and Wards 
entry point compared to those tested through the PMTCT entry point 59 (25%). This difference 
can be attributed to the relative high volumes of clients that are seen through the OPD for any 
kind of illness and those that are admitted in the hospital wards annually. The PMTCT entry 
point only caters for clients that access the antenatal, maternity and postnatal services at the 
hospital. It was also observed that more females 46(78%) than males 13(22%) were diagnosed 
through the PMTCT entry point. It was inferred that males that were diagnosed through the 
PMTCT entry point were accompanying their spouses who were accessing PMTCT services 
for pregnancy. There is need to recommend more testing of male spouses in PMTCT as this 
will help to reduce the risk of transmission of HIV to the child. The Ministry of Health and 
Child Care of Zimbabwe recommends for couple HIV testing during antenatal care as a way 
of eliminating mother to child to transmission of HIV (MoHCC, 2017:33).  
 In this study, linkage to HIV care referred to the first documented attendance for CD4 or the 
WHO clinical staging after a positive HIV diagnosis. Approximately 144 (60%) of the client 
records reviewed had documented evidence of having been linked to HIV care while 95 (40%) 
did not have any documented evidence of linkage to HIV care. There was a higher proportion 
of females 87(66 %) than males 57(53%) among those linked to HIV care although the 
variation was not statistically significant (p=0.062) at a 95% confidence interval. There were 
statistically significant variations (p=0.00002, CI 95%) in the proportions of client records with 
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documented evidence of linkage to HIV care between entry points for HIV testing. The 
PMTCT entry point had a higher proportion of its clients 50(85%) linked to HIV care as 
compared to the OPD and Wards entry point that had about 94(52%) of its clients linked to 
HIV care. 
  
The variations in the linkages to care between these entry points may be attributed to the 
different models of HIV care that are used in these entry points. The PMTCT entry point at the 
Norton Health Centre along with the whole of Zimbabwe adopted the Option B+ model for 
initiating ART in HIV positive pregnant women and breastfeeding women in 2013. In addition, 
the Option B+ is a policy that provides immediate and lifelong ART to all pregnant and 
breastfeeding women who test HIV positive (WHO, 2016:43). The high linkage to HIV care 
proportions for PMTCT clients correlates to the success stories of the Option B+ policy as 
reported by the WHO (2016:43) that has seen many HIV high burden countries reporting an 
uptake of more than 90% in HIV testing of pregnant women. Furthermore, it is believed that 
identifying HIV-positive pregnant women and promptly enrolling them in treatment has 
benefits for the woman, the infant and the woman’s sexual partner. 
 
The policies used in the Option B+ model are almost similar to the ‘Treat All” approach in that 
every person diagnosed with HIV is now eligible for lifelong ART (WHO, 2016:43;76). This 
means that at the time of the data collection for the study, all the clients who had been diagnosed 
with HIV prior to 2017 should have been linked to HIV care and treatment. Therefore, there 
were no differences in proportions of clients linked to care and treatment that were expected 
from the different entry points. The eligibility for ART enrolment in Zimbabwe was until late 
2016 based on a CD4 cell count equal to or less than 500 cells/mm3 or a WHO clinical stage 3 
and 4 (WHO, 2013:13). Of the clients’ records that were reviewed in the study period, 
approximately 119 (50%) had a documented CD4 test done and the other 120 (50%) had no 
record of a CD4 having been done. The median CD4 cell count for those clients that had a CD4 
test done was 523 cell/mm3 [240-867 cell/mm3]. About 59 (50%)of the clients that had a CD4 
cell count result were eligible for ART initiation and about 60(50%) would not been eligible 
for initiation at the time of HIV diagnosis based on the 500 cell/mm3 CD4 count threshold. 
More importantly, the higher median CD4 cell count recorded was a positive development as 
these clients would have a better treatment prognosis if initiated on ART. The WHO (2016) 
has cited growing evidence of the clinical benefits of earlier ART initiation. An analysis of the 
HPTN052 results found that study participants that were randomized to the early treatment arm 
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(CD4 cell count 250-500) had higher median CD4 counts during two years of follow-up. 
Specifically, they were 27% less likely to experience a primary clinical event, 36% less likely 
to experience an AIDS-defining clinical event and 51% less likely to be diagnosed with 
tuberculosis (UNAIDS, 2014:3). 
 
In terms of documented evidence for the WHO clinical staging, approximately 140(59%) of 
the clients had received the WHO clinical staging and about 99(41%) had no evidence of 
having received the WHO clinical staging. The highest number of the clients were documented 
to be in WHO clinical stage 2 which represented 71(51%) of the clients. There were no clients 
that were documented to be in the WHO clinical stage 4, which is the most severe stage of HIV 
infection. Of the clients who received the staging, about 30 (21%) of the clients were eligible 
for ART initiation at the time of HIV diagnosis based on the WHO clinical stage 3 or 4 
according to the WHO (2013) guidelines. 
 
Linkage to HIV treatment in this research was defined in Chapter 1 as documented initiation 
on ART following HIV diagnosis. Of the clients’ records that were reviewed, more clients had 
documented evidence of linkage to HIV treatment 143 (60%) than those that did not have any 
evidence of linkage to HIV treatment 96 (40%). The uptake of ART following HIV diagnosis 
for the period under study was relatively lower than the national uptake that was reported by 
ZIMPHIA (2017: 3) of 87.3% among people 15-64 years old who know their HIV status. When 
proportions for linkage to HIV treatment were assessed between gender, it was observed that 
females had a higher proportion of clients 66% that had documented evidence for linkage to 
HIV treatment as compared to the males that had 52% of the clients. This variation in 
proportions was statistically significant (p=0.046) at a 95% confidence interval.  
There was an almost balanced pattern in linkage to HIV treatment for the clients that were 
diagnosed through the OPD and Wards entry point which had about 93(52%) linked to HIV 
treatment while 87(48%) were not linked. For the PMTCT entry point, a greater proportion of 
the clients had documented linkage to HIV treatment 50(85%) compared to those with no 
linkage 9(15%). Furthermore, there was a statistically significant variation for the proportions 
of the linkage to HIV treatment between the entry points with the PMTCT entry point having 
a higher proportion (85%) compared to the OPD and Wards entry point (52%). This pattern 
may also be attributed to the availability of the Option B+ policy for ART initiation in the 
PMTCT entry point as discussed previously in the section above. 
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The process of linking clients that have been diagnosed with HIV at the Norton Health Centre 
is based on the HIV treatment cascade. The study went on to analyse the treatment cascade for 
the clients’ records that were reviewed during the study period for any linkage loss. The linkage 
loss can be defined as the missed opportunities for linkage to HIV care and treatment for clients 
diagnosed with HIV. It was observed that the greatest loss in clients occurred between HIV 
diagnosis and linkage to HIV care which had a linkage loss of about 40%. There was very little 
linkage loss observed between HIV care and ART initiation (1%).  
 
5.4 HYPOTHESIS TESTING 
In this study, the findings demonstrated statistically significant variations in proportions for 
linkage to HIV care and treatment between the entry points of testing led to the researcher 
failing to reject the hypotheses:  
• H1: There is a significant relationship between the entry point from which clients are 
diagnosed with HIV at the facility and the linkage to HIV care and treatment.  
This hypothesis is accepted based on the following findings of this study: 
There was a statistically significant variation in proportions of clients with documented 
evidence of linkage to HIV care between entry points (p=0.00002) at 95% confidence interval. 
The high numbers of linked clients as shown in Figure 5.1 below demonstrate this. 
 
 
Figure 5.1: Linkage to HIV care by entry point 
As demonstrated in Figure 5.1 above, there were more clients that were linked to HIV care and 
treatment from both entry points at Norton Health Centre. PMTCT had the highest linkages, 
which then calls for people to be encouraged to use this entry point including men, as there 
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were few identified to have used this entry point. This should be done when encouraging 
expectant females to come with their male partners. 
• H2: There are more HIV positive females linked to HIV care and treatment than HIV 
positive males at the health facility.  
This hypothesis is accepted based on the following findings of the study: 
 
Figure 5.2: Linkage to HIV care and treatment by gender 
Based on the findings as shown in Figure 5.2 above, it was concluded that the hypothesis be 
accepted. It was also concluded that clients diagnosed with HIV between January 2016 and 
December 2016 which was the study period, there were more females linked to HIV care and 
treatment than the males at Norton Health Centre. There is a need to make sure that measures 
are put in place that encourage clients especially males that are diagnosed with HIV at the 
health centre to be linked to HIV care and treatment. More importantly, ensuring that all clients 
that are diagnosed with HIV are effectively linked to care and treatment may help in improving 
the treatment outcomes of the individual and drive towards the elimination of the spread of the 
HIV infection. 
5.5 LIMITATIONS OF THE STUDY 
Some limitations to this study were noted. The findings of this study cannot be generalised to 
the whole Norton town as the study was conducted using the records of clients that were seen 
at one health centre as opposed many health centres that exist in this town. There are 
possibilities that some of the clients documented as not linked to care and treatment could have 
accessed these services from other facilities. 
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The retrospective design that was used meant that the researcher had to put up with the 
documentation errors that existed. Some client records had gaps in terms of documentation of 
the services the client would have received. Nevertheless, these identified gaps did not have 
any effect on the results and findings. Where the gaps had significant effect on the study, the 
researcher made all attempts to find the missing information. The information used in the study 
was collected sorely from the client records to determine the linkage outcomes. Yet other 
factors at institution level could have had an influence on the treatment outcomes. 
5.6 RECOMMENDATIONS 
Based on the findings of this study, conclusions and limitations discussed in the sections above, 
the following recommendations are made for both the health centre and the research 
community aimed at improving the linkages of people living with HIV to effective care and 
lifelong treatment. 
5.6.1 Recommendations for the Health Centre 
It was noted that there is a significant association between the entry point from which HIV 
diagnosis is done and the subsequent linkage to care and treatment outcomes at the Norton 
Health Centre. It was also noted that more females were linked to HIV care and treatment than 
males. In light of these findings, the following recommendations were made: 
• To implement programmes that are meant to make HIV testing services easily 
accessible to key populations like men, the adolescents and young people.  
• To ensure that the health centre identifies all the bottlenecks that maybe hindering the 
effective linkage of all diagnosed clients to HIV care and treatment.  
• There is also need to learn lessons from the certain sections of the systems that will be 
performing well to help improve services in the other sections. Lessons can be learnt 
from the PMTCT entry point that can help the OPD and Wards improve its linkages to 
care and treatment. 
• The study also showed few men who used PMTCT as an entry point. It is also 
recommended that male partners be encouraged to accompany their expectant female 
partners attending the PMTCT sessions. 
• There is need to have multiple entry points at the health centre as opposed to having 
one entry point that caters for all the OPD clients without specific points that cater for 
STI, TB clients as recommended in the Operation and Service Delivery Manual for the 
Prevention, Care and Treatment of HIV in Zimbabwe (MoHCC, 2017). 
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5.6.2 Recommendations for future research 
Based on the findings of this study, the following recommendations were made for further 
research to: 
• To determine the health facility, health staff bottlenecks and enablers to improving 
linkages to HIV care and treatment for people diagnosed with HIV. 
• To investigate on how various social, cultural and psychological standings of people 
diagnosed with HIV may interact with the linkages to care and treatment. 
• To determine the treatment retention patterns of clients following initiation on lifelong 
ART. 
• To prospectively follow a cohort of newly diagnosed HIV clients to establish factors 
they go through in their journey towards viral suppression. 
• Qualitative research that will explore and describe the reasons for not being linked to 
treatment and care especially for the HIV positive men. 
• Destigmatisation of the HIV infection studies among the youth and young adults as 
there was few that were linked to HIV care and treatment.  
• Mixed methods research that will use the clients’ own views and perceptions rather than 
using the records only. 
5.6.3 Recommendations for public health 
• More health education to destigmatise the HIV infections to have community being 
open about their HIV status. 
• Involvement of community health care workers in the follow-up on defaulters. 
• Involvement of community-based facilities like churches and societies to pass on 
education. 
• The community-based health care centres to be equipped with more staff and 
equipment to deal with the demands of the community. 
• Youth friendly services for the young adults to be encouraged where youths can 
have their own centre to share their feelings. 
• The centres to have the facility tracking system that will assist in identifying the 
defaulters.  
• Health care centres to use the mobile devices (eHealth) to remind the clients about 
their appointments. 
• Health care facilities to operate for the whole week to cater for the working class 
clients. 
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6.0 CONCLUSION  
This chapter presented a summary of the research findings, the conclusions that were reached 
on based on the findings of the study. The recommendations and the study limitations were 
discussed. The aim of this study as discussed in Chapter One, was to determine the proportions 
of linkages to HIV care and treatment as per entry point for the people diagnosed with HIV at 
a Norton Health Centre. The study also sought to make recommendations to improve linkages 
to HIV care and treatment per entry point where there is a need. The study managed to meet 
the following objectives: 
• To determine the proportion of individuals diagnosed with HIV that had documented 
evidence of linkage to HIV care and treatment at a Norton Health Centre by entry point. 
This objective was met through the demonstrated proportions of linkages to HIV care 
and treatment that were presented in Chapter 4 of the study. 
• To evaluate the association between the entry point of HIV diagnosis and the linkage 
to HIV care and treatment. Based on the findings of the study, a statistically significant 
variation in proportions of clients with documented evidence of linkage to HIV care 
between entry points (p=0.00002) at 95% confidence interval. 
• To make recommendations for improving the linkages to HIV care and treatment as per 
entry point at a Norton Health Centre. Recommendations were made based on the 
findings of the study. These recommendations were targeted at the health centre, future 
research and public health development. 
The findings of the study led to acceptance of the hypotheses that there is a significant 
relationship between the entry point from which clients are diagnosed with HIV at the facility 
and the linkage to HIV care and treatment. The second hypotheses that there are more HIV 
positive females linked to HIV care and treatment than HIV positive males at the health facility 
was also accepted based on the research findings. 
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ANNEXURE B 
 REQUEST TO CONDUCT RESEARCH 
                            
 
 
 
 
 
REQUEST FOR PERMISSION TO CONDUCT RESEARCH  
Norton Town Council  
Department of Health  
Norton, Zimbabwe  
 
19 June 2017  
Dear Sir/ Madam  
RE: Application for permission to conduct research at the health centre  
My name is Nigel Leon Tungwarara currently studying for a Masters in Public Health (MPH) 
degree with the University of South Africa (UNISA). I am conducting a research titled: 
“Facility linkages to HIV care and treatment as per entry point at a Norton health centre, 
Zimbabwe”. The research will be conducted under the supervision of Dr DD Mphuthi from the 
UNISA Department of Health Studies. I would like to apply for permission to conduct this 
research at Norton District Hospital.  
This study aims to investigate the losses to linkages to HIV care and treatment for the clients 
diagnosed with HIV that occur in the various entry points providing HIV testing at the hospital. 
This will allow recommendations to be made that can improve linkages in the entry points. The 
health centre has been selected for this study because it is located in a small town that is 
surrounded by mining and farming communities which are a HIV transmission high risk areas. 
The study will involve collecting information from the hospital registers on clients who were 
diagnosed of HIV between January and December 2016 through various entry points and 
determining if they managed to be linked to HIV care and initiated on antiretroviral therapy. 
The individual client identifiers like names will not be recorded so as maintain the privacy and 
anonymity. The recorded information will be kept in a safe place and will only be accessed by 
those people or institutions directly involved with the research.  
The findings from this study will help in identifying the entry points that will be having 
significantly low linkages to care and treatment which can help to identify any bottlenecks in 
these entry points. The findings can also be used as a baseline for any program that will be 
implemented to improve the linkages to care and treatment. A bound copy of the full research 
copy will be provided to the health centre upon completion of the study. Should any further  
information be required, I can be contacted on mobile phone number: +263 777 369 590 and 
email: nigelltung@gmail.com. My supervisor Dr DD Mphuthi can be contacted on email: 
mphutdd@unisa.ac.za.  
Yours Sincerely  
Nigel Tungwarara 
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